BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47:2089-111. [PMID: 18506894 DOI: 10.1002/hep.22261] [Cited by in Crossref: 827] [Cited by in F6Publishing: 613] [Article Influence: 59.1] [Reference Citation Analysis]
Number Citing Articles
1 Michniewicz F, Saletta F, Rouaen JRC, Hewavisenti RV, Mercatelli D, Cirillo G, Giorgi FM, Trahair T, Ziegler D, Vittorio O. Copper: An Intracellular Achilles' Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics. ChemMedChem 2021;16:2315-29. [PMID: 33890721 DOI: 10.1002/cmdc.202100172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jaurigue MM, Cappell MS. Therapy for alcoholic liver disease. World J Gastroenterol 2014; 20(9): 2143-2158 [PMID: 24605013 DOI: 10.3748/wjg.v20.i9.2143] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
3 Cheng N, Wang H, Dong J, Pan S, Wang X, Han Y, Han Y, Yang R. Elevated serum brain natriuretic peptide and matrix metalloproteinases 2 and 9 in Wilson's disease. Metab Brain Dis 2015;30:1087-91. [PMID: 26077744 DOI: 10.1007/s11011-015-9685-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Dong Y, Wu ZY. Challenges and suggestions for precise diagnosis and treatment of Wilson's disease. World J Pediatr 2021;17:561-5. [PMID: 34714531 DOI: 10.1007/s12519-021-00475-4] [Reference Citation Analysis]
5 Tamás G, Raethjen J, Muthuraman M, Folhoffer A, Deuschl G, Szalay F, Takáts A, Kamondi A. Disturbed post-movement beta synchronization in Wilson's disease with neurological manifestation. Neurosci Lett 2011;494:240-4. [PMID: 21406212 DOI: 10.1016/j.neulet.2011.03.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Trocello JM, El Balkhi S, Woimant F, Girardot-Tinant N, Chappuis P, Lloyd C, Poupon J. Relative exchangeable copper: a promising tool for family screening in Wilson disease. Mov Disord. 2014;29:558-562. [PMID: 24375554 DOI: 10.1002/mds.25763] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
7 Tisato F, Marzano C, Porchia M, Pellei M, Santini C. Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev 2010;30:708-49. [PMID: 19626597 DOI: 10.1002/med.20174] [Cited by in Crossref: 71] [Cited by in F6Publishing: 102] [Article Influence: 5.9] [Reference Citation Analysis]
8 Kim S, Song IU, Chung YA, Choi EK, Oh JK. Brain MRI, Tc-99m HMPAO SPECT and F-18 FP-CIT PET/CT Findings in a Patient with Wilson Disease: A Case Report. Nucl Med Mol Imaging 2014;48:303-5. [PMID: 26396635 DOI: 10.1007/s13139-014-0290-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Wang DW, Yin YM, Yao YM. Advances in the management of acute liver failure. World J Gastroenterol 2013; 19(41): 7069-7077 [PMID: 24222950 DOI: 10.3748/wjg.v19.i41.7069] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
10 Xu R, Jiang YF, Zhang YH, Yang X. The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital-based study. PLoS One 2018;13:e0190887. [PMID: 29324775 DOI: 10.1371/journal.pone.0190887] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Graziadei I, Zoller H, Fickert P, Schneeberger S, Finkenstedt A, Peck-Radosavljevic M, Müller H, Kohl C, Sperner-Unterweger B, Eschertzhuber S, Hofer H, Öfner D, Tilg H, Vogel W, Trauner M, Berlakovich G. Indications for liver transplantation in adults : Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX). Wien Klin Wochenschr 2016;128:679-90. [PMID: 27590261 DOI: 10.1007/s00508-016-1046-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
12 Patel R. Wilson disease: a diagnostic challenge in a patient with alcoholic liver disease. BMJ Case Rep 2019;12:e232449. [PMID: 31653639 DOI: 10.1136/bcr-2019-232449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Squitti R, Siotto M, Ivanova I, Rongioletti M. ATP7B and Alzheimer Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 427-36. [DOI: 10.1016/b978-0-12-810532-0.00042-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Litwin T, Gromadzka G, Członkowska A. Apolipoprotein E gene (APOE) genotype in Wilson's disease: impact on clinical presentation. Parkinsonism Relat Disord 2012;18:367-9. [PMID: 22221592 DOI: 10.1016/j.parkreldis.2011.12.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
15 García-Cortés M, Ortega-Alonso A, Andrade RJ. Safety of treating acute liver injury and failure. Expert Opin Drug Saf 2021;:1-13. [PMID: 34254839 DOI: 10.1080/14740338.2021.1955854] [Reference Citation Analysis]
16 Sintusek P, Kyrana E, Dhawan A. Value of Serum Zinc in Diagnosing and Assessing Severity of Liver Disease in Children With Wilson Disease. Journal of Pediatric Gastroenterology & Nutrition 2018;67:377-82. [DOI: 10.1097/mpg.0000000000002007] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 To U, Schilsky ML. Introduction to Copper Metabolism and Wilson Disease. In: Schilsky ML, editor. Management of Wilson Disease. Cham: Springer International Publishing; 2018. pp. 1-16. [DOI: 10.1007/978-3-319-91527-2_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Yu XE, Pan M, Han YZ, Yang RM, Wang J, Gao S. The study of Wilson disease in pregnancy management. BMC Pregnancy Childbirth 2019;19:522. [PMID: 31878905 DOI: 10.1186/s12884-019-2641-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Cheng N, Wang K, Hu W, Sun D, Wang X, Hu J, Yang R, Han Y. Wilson disease in the South chinese han population. Can J Neurol Sci 2014;41:363-7. [PMID: 24718822 DOI: 10.1017/s0317167100017315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
20 Hegde RN, Subramanian A, Pothukuchi P, Parashuraman S, Luini A. Rare ER protein misfolding-mistrafficking disorders: Therapeutic developments. Tissue Cell 2017;49:175-85. [PMID: 28222887 DOI: 10.1016/j.tice.2017.02.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
21 Stremmel W, Merle U. Liver: A new copper cut-off value for diagnosis of Wilson disease? Nat Rev Gastroenterol Hepatol 2015;12:493-4. [PMID: 26260373 DOI: 10.1038/nrgastro.2015.132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Lin LJ, Wang DX, Ding NN, Lin Y, Jin Y, Zheng CQ. Comprehensive analysis on clinical features of Wilson's disease: an experience over 28 years with 133 cases. Neurol Res. 2014;36:157-163. [PMID: 24107488 DOI: 10.1179/1743132813y.0000000262] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
23 Tapper EB, Sengupta N, Lai M, Horowitz G. Understanding and Reducing Ceruloplasmin Overuse with a Decision Support Intervention for Liver Disease Evaluation. Am J Med 2016;129:115.e17-22. [PMID: 26254122 DOI: 10.1016/j.amjmed.2015.07.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
24 Hahn SH. Population screening for Wilson's disease. Ann N Y Acad Sci 2014;1315:64-9. [PMID: 24731025 DOI: 10.1111/nyas.12423] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
25 Kumar SS, Kurian G, Eapen CE, Roberts EA. Genetics of Wilson's disease: a clinical perspective. Indian J Gastroenterol 2012;31:285-93. [PMID: 22941676 DOI: 10.1007/s12664-012-0237-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Ranucci G, Socha P, Iorio R. Wilson disease: What is still unclear in pediatric patients? Clinics and Research in Hepatology and Gastroenterology 2014;38:268-72. [DOI: 10.1016/j.clinre.2014.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
27 Członkowska A, Rodo M, Wierzchowska-Ciok A, Smolinski L, Litwin T. Accuracy of the radioactive copper incorporation test in the diagnosis of Wilson disease. Liver Int 2018;38:1860-6. [PMID: 29418065 DOI: 10.1111/liv.13715] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Harada M, Honma Y, Yoshizumi T, Kumamoto K, Oe S, Harada N, Tanimoto A, Yabuki K, Karasuyama T, Yoneda A, Shibata M. Idiopathic copper toxicosis: is abnormal copper metabolism a primary cause of this disease? Med Mol Morphol 2020;53:50-5. [DOI: 10.1007/s00795-019-00227-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
29 Schilsky ML. Wilson Disease: Diagnosis, Treatment, and Follow-up. Clin Liver Dis. 2017;21:755-767. [PMID: 28987261 DOI: 10.1016/j.cld.2017.06.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 7.6] [Reference Citation Analysis]
30 Júlvez J, Dikicioglu D, Oliver SG. Handling variability and incompleteness of biological data by flexible nets: a case study for Wilson disease. NPJ Syst Biol Appl 2018;4:7. [PMID: 29354285 DOI: 10.1038/s41540-017-0044-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
31 Sampaziotis F, Segeritz CP, Vallier L. Potential of human induced pluripotent stem cells in studies of liver disease. Hepatology 2015;62:303-11. [PMID: 25502113 DOI: 10.1002/hep.27651] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
32 Glavind E, Gotthardt DN, Pfeiffenberger J, Sandahl TD, Bashlekova T, Willemoe GL, Hasselby JP, Weiss KH, Møller HJ, Vilstrup H, Lee WM, Schilsky ML, Ott P, Grønbæk H. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease. Orphanet J Rare Dis 2020;15:173. [PMID: 32615997 DOI: 10.1186/s13023-020-01452-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lakatos PL, Kiss LS, Miheller P. Nutritional influences in selected gastrointestinal diseases. Dig Dis. 2011;29:154-165. [PMID: 21734379 DOI: 10.1159/000323878] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 Yu Y, Guerrero CR, Liu S, Amato NJ, Sharma Y, Gupta S, Wang Y. Comprehensive Assessment of Oxidatively Induced Modifications of DNA in a Rat Model of Human Wilson's Disease. Mol Cell Proteomics 2016;15:810-7. [PMID: 26362317 DOI: 10.1074/mcp.M115.052696] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 4.1] [Reference Citation Analysis]
35 Nameki S, Maeda Y, Shibahara T, Fukui J, Shimizu T, Bessho K, Fujiwara H. Refractory liver dysfunction was remarkably improved with chelating agents of Wilson's disease, in a patient with systemic lupus erythematosus-like syndrome after a parvovirus B19 infection. Mod Rheumatol Case Rep 2021;5:182-7. [PMID: 33019911 DOI: 10.1080/24725625.2020.1832754] [Reference Citation Analysis]
36 Roberts EA. “Not so rare” Wilson disease. Clinics and Research in Hepatology and Gastroenterology 2013;37:219-21. [DOI: 10.1016/j.clinre.2013.03.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
37 Wagner S, Brunet A, Bost M, Lachaux A, Broussolle E, Des Portes V, Lion-françois L. Maladie de Wilson, penser aux formes neurologiques chez l’enfant. Archives de Pédiatrie 2012;19:271-6. [DOI: 10.1016/j.arcped.2011.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Litwin T, Dusek P, Czlonkowska A. Neurological manifestations in Wilson’s disease –possible treatment options for symptoms. Expert Opinion on Orphan Drugs 2016;4:719-28. [DOI: 10.1080/21678707.2016.1188003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
39 Cao C, Colangelo T, Dhanekula RK, Brandt D, Laothamatas I, Thapar M, Herrine SK, Civan JM. A Rare Case of Wilson Disease in a 72-Year-Old Patient. ACG Case Rep J 2019;6:1-3. [PMID: 31620489 DOI: 10.14309/crj.0000000000000024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
40 Yang X, Tang XP, Zhang YH, Luo KZ, Jiang YF, Luo HY, Lei JH, Wang WL, Li MM, Chen HC, Deng SL, Lai LY, Liang J, Zhang M, Tian Y, Xu Y. Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample. Hepatology 2015;62:1731-41. [PMID: 26095812 DOI: 10.1002/hep.27932] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 5.1] [Reference Citation Analysis]
41 Lichtmannegger J, Leitzinger C, Wimmer R, Schmitt S, Schulz S, Kabiri Y, Eberhagen C, Rieder T, Janik D, Neff F, Straub BK, Schirmacher P, DiSpirito AA, Bandow N, Baral BS, Flatley A, Kremmer E, Denk G, Reiter FP, Hohenester S, Eckardt-Schupp F, Dencher NA, Adamski J, Sauer V, Niemietz C, Schmidt HH, Merle U, Gotthardt DN, Kroemer G, Weiss KH, Zischka H. Methanobactin reverses acute liver failure in a rat model of Wilson disease. J Clin Invest 2016;126:2721-35. [PMID: 27322060 DOI: 10.1172/JCI85226] [Cited by in Crossref: 77] [Cited by in F6Publishing: 37] [Article Influence: 12.8] [Reference Citation Analysis]
42 Kenaan A, Brunel F, Raimundo J, Charrier A. Femtomolar detection of Cu2+ ions in solution using super-Nernstian FET-sensor with a lipid monolayer as top-gate dielectric. Sensors and Actuators B: Chemical 2020;316:128147. [DOI: 10.1016/j.snb.2020.128147] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
43 Solovyev N, Ala A, Schilsky M, Mills C, Willis K, Harrington CF. Biomedical copper speciation in relation to Wilson’s disease using strong anion exchange chromatography coupled to triple quadrupole inductively coupled plasma mass spectrometry. Analytica Chimica Acta 2020;1098:27-36. [DOI: 10.1016/j.aca.2019.11.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
44 Wu F, Wang J, Pu C, Qiao L, Jiang C. Wilson's disease: a comprehensive review of the molecular mechanisms. Int J Mol Sci. 2015;16:6419-6431. [PMID: 25803104 DOI: 10.3390/ijms16036419] [Cited by in Crossref: 59] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
45 Mohagheghi S, Khajehahmadi Z, Nikeghbalian S, Alavian SM, Doosti-Irani A, Khodadadi I, Karimi J, Sharafi H, Tavilani H. Changes in the distribution of etiologies of cirrhosis among patients referred for liver transplantation over 11 years in Iran. Eur J Gastroenterol Hepatol 2020;32:844-50. [PMID: 31688307 DOI: 10.1097/MEG.0000000000001590] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Pugliese M, Biondi V, Gugliandolo E, Licata P, Peritore AF, Crupi R, Passantino A. D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective. Antibiotics (Basel) 2021;10:648. [PMID: 34071639 DOI: 10.3390/antibiotics10060648] [Reference Citation Analysis]
47 Hachmöller O, Zibert A, Zischka H, Sperling M, Groba SR, Grünewald I, Wardelmann E, Schmidt HH, Karst U. Spatial investigation of the elemental distribution in Wilson’s disease liver after d -penicillamine treatment by LA-ICP-MS. Journal of Trace Elements in Medicine and Biology 2017;44:26-31. [DOI: 10.1016/j.jtemb.2017.05.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
48 Das MC, Sen Sarma M, Srivastava A, Yachha SK, Poddar U. Effect of chelation therapy in pediatric Wilson's disease: Liver and endoscopic outcome. J Hepatobiliary Pancreat Sci 2021;28:336-45. [PMID: 32745371 DOI: 10.1002/jhbp.812] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Ranjan A, Kalita J, Kumar V, Misra UK. MRI and oxidative stress markers in neurological worsening of Wilson disease following penicillamine. Neurotoxicology. 2015;49:45-49. [PMID: 26004675 DOI: 10.1016/j.neuro.2015.05.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
50 Lamboux A, Couchonnal-Bedoya E, Guillaud O, Laurencin C, Lion-François L, Belmalih A, Mintz E, Brun V, Bost M, Lachaux A, Balter V. The blood copper isotopic composition is a prognostic indicator of the hepatic injury in Wilson disease. Metallomics 2020;12:1781-90. [PMID: 33057522 DOI: 10.1039/d0mt00167h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Rasib AR, Aziz Jabarkhil A, Sediqi MF, Mansoor AI, Asady A. Wilson's Disease Presenting with Generalized Tonic-Clonic Seizure and Cerebellar Dysfunction. Int Med Case Rep J 2021;14:529-32. [PMID: 34393521 DOI: 10.2147/IMCRJ.S320639] [Reference Citation Analysis]
52 Pal A, Prasad R. An overview of various mammalian models to study chronic copper intoxication associated Alzheimer’s disease like pathology. Biometals 2015;28:1-9. [DOI: 10.1007/s10534-014-9799-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
53 Hayashi H, Tatsumi Y, Yahata S, Hayashi H, Momose K, Isaji R, Sasaki Y, Hayashi K, Wakusawa S, Goto H. Acute Hepatic Phenotype of Wilson Disease: Clinical Features of Acute Episodes and Chronic Lesions Remaining in Survivors. J Clin Transl Hepatol 2015;3:239-45. [PMID: 26807378 DOI: 10.14218/JCTH.2015.00032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
54 Roberts EA. Autoimmune hepatitis from the paediatric perspective. Liver International 2011;31:1424-31. [DOI: 10.1111/j.1478-3231.2011.02603.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
55 Jończy A, Lipiński P, Ogórek M, Starzyński RR, Krzysztofik D, Bednarz A, Krzeptowski W, Szudzik M, Haberkiewicz O, Miłoń A, Grzmil P, Lenartowicz M. Functional iron deficiency in toxic milk mutant mice (tx-J) despite high hepatic ferroportin: a critical role of decreased GPI-ceruloplasmin expression in liver macrophages. Metallomics 2019;11:1079-92. [PMID: 31011744 DOI: 10.1039/c9mt00035f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
56 Pfeiffenberger J, Lohse CM, Gotthardt D, Rupp C, Weiler M, Teufel U, Weiss KH, Gauss A. Long‐term evaluation of urinary copper excretion and non‐caeruloplasmin associated copper in Wilson disease patients under medical treatment. J Inherit Metab Dis 2019;42:371-80. [DOI: 10.1002/jimd.12046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
57 Rodríguez B, Burguera J, Berenguer M. Response to different therapeutic approaches in Wilson disease. A long-term follow up study. Annals of Hepatology 2012;11:907-14. [DOI: 10.1016/s1665-2681(19)31417-6] [Cited by in Crossref: 10] [Article Influence: 1.0] [Reference Citation Analysis]
58 van de Wardt J, van der Stouwe AMM, Dirkx M, Elting JWJ, Post B, Tijssen MA, Helmich RC. Systematic clinical approach for diagnosing upper limb tremor. J Neurol Neurosurg Psychiatry 2020;91:822-30. [PMID: 32457087 DOI: 10.1136/jnnp-2019-322676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
59 Kalita J, Naik S, Bhoi SK, Misra UK, Ranjan A, Kumar S. Pontomesencephalic Atrophy and Postural Instability in Wilson Disease. AJNR Am J Neuroradiol 2017;38:1343-7. [PMID: 28495941 DOI: 10.3174/ajnr.A5207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
60 Feng H, Fu Q, Du W, Zhu R, Ge X, Wang C, Li Q, Su L, Yang H, Song J. Quantitative Assessment of Copper(II) in Wilson's Disease Based on Photoacoustic Imaging and Ratiometric Surface-Enhanced Raman Scattering. ACS Nano 2021;15:3402-14. [PMID: 33508938 DOI: 10.1021/acsnano.0c10407] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
61 Seetharam A. Intensive Care Management of Acute Liver Failure: Considerations While Awaiting Liver Transplantation. J Clin Transl Hepatol 2019;7:384-91. [PMID: 31915608 DOI: 10.14218/JCTH.2019.00032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
62 Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, Ferenci P, Stremmel W. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology 2011; 140: 1189-1198. e1. [PMID: 21185835 DOI: 10.1053/j.gastro.2010.12.034] [Cited by in Crossref: 120] [Cited by in F6Publishing: 91] [Article Influence: 10.0] [Reference Citation Analysis]
63 Dusek P, Aaseth J. Chelating Therapy in Metal Storage Diseases. Chelation Therapy in the Treatment of Metal Intoxication. Elsevier; 2016. pp. 285-311. [DOI: 10.1016/b978-0-12-803072-1.00006-7] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
64 Agrawal S, Dhiman RK. Hepatobiliary quiz-9 (2014). J Clin Exp Hepatol 2014;4:81-4. [PMID: 25755542 DOI: 10.1016/j.jceh.2014.03.054] [Reference Citation Analysis]
65 Russell K, Gillanders LK, Orr DW, Plank LD. Dietary copper restriction in Wilson's disease. Eur J Clin Nutr 2018;72:326-31. [PMID: 29235558 DOI: 10.1038/s41430-017-0002-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
66 Yuan XZ, Yang RM, Wang XP. Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy. Curr Neuropharmacol 2021;19:465-85. [PMID: 32351182 DOI: 10.2174/1570159X18666200429233517] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Ryan A, Nevitt SJ, Tuohy O, Cook P. Biomarkers for diagnosis of Wilson's disease. Cochrane Database Syst Rev 2019;2019. [PMID: 31743430 DOI: 10.1002/14651858.CD012267.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
68 Dufernez F, Lachaux A, Chappuis P, De Lumley L, Bost M, Woimant F, Misrahi M, Debray D. Wilson disease in offspring of affected patients: Report of four French families. Clinics and Research in Hepatology and Gastroenterology 2013;37:240-5. [DOI: 10.1016/j.clinre.2013.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
69 Larner F, Sampson B, Rehkämper M, Weiss DJ, Dainty JR, O'riordan S, Panetta T, Bain PG. High precision isotope measurements reveal poor control of copper metabolism in Parkinsonism. Metallomics 2013;5:125. [DOI: 10.1039/c3mt20238k] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
70 Duncan A, Harrington CF, Catchpole A, Taylor A. Is the measurement of copper and iron in liver biopsies reliable? Results from a pilot external quality assurance scheme. J Trace Elem Med Biol 2019;52:288-92. [PMID: 30732894 DOI: 10.1016/j.jtemb.2019.01.009] [Reference Citation Analysis]
71 Chanpong A, Dhawan A. Long-Term Urinary Copper Excretion on Chelation Therapy in Children with Wilson Disease. J Pediatr Gastroenterol Nutr 2021;72:210-5. [PMID: 33369596 DOI: 10.1097/MPG.0000000000002982] [Reference Citation Analysis]
72 Wiernicka A, Jańczyk W, Dądalski M, Avsar Y, Schmidt H, Socha P. Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate. World J Gastroenterol 2013; 19(27): 4356-4362 [PMID: 23885147 DOI: 10.3748/wjg.v19.i27.4356] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
73 Sukezaki A, Chu PS, Shinoda M, Hibi T, Taniki N, Yoshida A, Kawaida M, Hori S, Morikawa R, Kurokouchi A, Wakino S, Kameyama K, Obara H, Kitagawa Y, Saito H, Kanai T, Nakamoto N. Late-onset acute liver failure due to Wilson's disease managed by plasmapheresis and hemodiafiltration successfully serving as a bridge for deceased donor liver transplantation: a case report and literature review. Clin J Gastroenterol 2020;13:1239-46. [PMID: 32643122 DOI: 10.1007/s12328-020-01175-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Kerkhof M, Honkoop P. Never forget aceruloplasminemia in case of highly suggestive Wilson's disease score. Hepatology 2014;59:1645-7. [PMID: 24002824 DOI: 10.1002/hep.26719] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
75 Di Stefano V, Lionetti E, Rotolo N, La Rosa M, Leonardi S. Hypercalciuria and nephrocalcinosis as early feature of Wilson disease onset: description of a pediatric case and literature review. Hepat Mon 2012;12:e6233. [PMID: 23087754 DOI: 10.5812/hepatmon.6233] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
76 Coni P, Pichiri G, Lachowicz JI, Ravarino A, Ledda F, Fanni D, Gerosa C, Piras M, Coghe F, Gibo Y, Cau F, Castagnola M, Van Eyken P, Saba L, Piludu M, Faa G. Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury. Molecules 2021;26:6614. [PMID: 34771023 DOI: 10.3390/molecules26216614] [Reference Citation Analysis]
77 Moini M, To U, Schilsky ML. Recent advances in Wilson disease. Transl Gastroenterol Hepatol 2021;6:21. [PMID: 33824925 DOI: 10.21037/tgh-2020-02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Pfeiffenberger J, Lohse CM, Gotthardt D, Rupp C, Weiler M, Teufel U, Weiss KH, Gauss A. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. J Inherit Metab Dis. [DOI: 10.1007/s10545-018-0218-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Kalita J, Kumar V, Misra UK, Parashar V, Ranjan A. Adjunctive Antioxidant Therapy in Neurologic Wilson’s Disease Improves the Outcomes. J Mol Neurosci 2020;70:378-85. [DOI: 10.1007/s12031-019-01423-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
80 Huster D, Hermann W, Bartels M. [Acute Wilson disease]. Internist (Berl) 2011;52:815-22. [PMID: 21633804 DOI: 10.1007/s00108-010-2794-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
81 Chen DB, Feng L, Lin XP, Zhang W, Li FR, Liang XL, Li XH. Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice. PLoS One 2012;7:e37709. [PMID: 22629446 DOI: 10.1371/journal.pone.0037709] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
82 Muñoz-Ortego J, Lara J, Navarro Ferrando JT. [A 21 year-old woman with fever, arthralgia and leucocitosis]. Med Clin (Barc) 2011;136:31-7. [PMID: 20889167 DOI: 10.1016/j.medcli.2010.07.003] [Reference Citation Analysis]
83 Kumar V, Singh AP, Wheeler N, Galindo CL, Kim JJ. Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system. Expert Opin Drug Saf 2021;:1-8. [PMID: 34259127 DOI: 10.1080/14740338.2021.1956460] [Reference Citation Analysis]
84 Nia S. Psychiatric signs and symptoms in treatable inborn errors of metabolism. J Neurol 2014;261 Suppl 2:S559-68. [PMID: 25145892 DOI: 10.1007/s00415-014-7396-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
85 Bhattacharjee S, Chatterjee S, Jiang J, Sinha BK, Mason RP. Detection and imaging of the free radical DNA in cells--site-specific radical formation induced by Fenton chemistry and its repair in cellular DNA as seen by electron spin resonance, immuno-spin trapping and confocal microscopy. Nucleic Acids Res 2012;40:5477-86. [PMID: 22387463 DOI: 10.1093/nar/gks180] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
86 Kalita J, Kumar V, Misra UK, Ranjan A, Khan H, Konwar R. A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings. Journal of Neuroimmunology 2014;274:141-8. [DOI: 10.1016/j.jneuroim.2014.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
87 Lacaille F. Other genetic liver diseases in children. Clin Res Hepatol Gastroenterol 2012;36:301-3. [PMID: 22541062 DOI: 10.1016/j.clinre.2012.03.027] [Reference Citation Analysis]
88 Honma Y, Harada M, Sato M, Katsuki Y, Hiura M, Shibata M, Narita R, Harada R, Abe S, Tabaru A, Tajiri N, Shimajiri S. Late diagnosed Wilson disease with hepatic and neurological manifestations: Late diagnosed Wilson disease. Hepatology Research 2011;41:270-6. [DOI: 10.1111/j.1872-034x.2010.00754.x] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
89 Tan MB, McAdory LE. Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts. J Radiol Case Rep 2016;10:1-10. [PMID: 27200161 DOI: 10.3941/jrcr.v10i3.2686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
90 Scorza M, Elce A, Zarrilli F, Liguori R, Amato F, Castaldo G. Genetic diseases that predispose to early liver cirrhosis. Int J Hepatol 2014;2014:713754. [PMID: 25132997 DOI: 10.1155/2014/713754] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
91 Altraif I, Handoo FA, Al Ghamdi H, Aljumah A, Al Jumah M, Afzal M. Presentation, diagnosis and outcome of predominantly hepatic Wilson's disease in adult Saudi patients: a single centre experience. Saudi J Gastroenterol 2012;18:334-8. [PMID: 23006462 DOI: 10.4103/1319-3767.101135] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Maxwell KL, Kowdley KV. Metals and the liver: . Current Opinion in Gastroenterology 2012;28:217-22. [DOI: 10.1097/mog.0b013e3283521d82] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
93 Gunjan D, Shalimar, Nadda N, Kedia S, Nayak B, Paul SB, Gamanagatti SR, Acharya SK. Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease. J Clin Exp Hepatol 2017;7:152-4. [PMID: 28663680 DOI: 10.1016/j.jceh.2016.09.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
94 Mageed SA, Rawla P, Mahmoud MA, Shahba A. Systemic lupus erythematosus, hypoparathyroidism, and hemolytic anemia in a patient with Wilson's disease. Reumatologia 2019;57:239-42. [PMID: 31548751 DOI: 10.5114/reum.2019.87622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
95 Güngör Ş, Selimoğlu MA, Bağ HGG, Varol FI. Is it possible to diagnose fulminant Wilson's disease with simple laboratory tests? Liver Int 2020;40:155-62. [PMID: 31568639 DOI: 10.1111/liv.14263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
96 Hefter H, Samadzadeh S. Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson's Disease: Six Cases and Literature Review. Toxins (Basel) 2021;13:241. [PMID: 33805281 DOI: 10.3390/toxins13040241] [Reference Citation Analysis]
97 Mak CM. Biochemical Diagnosis of Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 237-48. [DOI: 10.1016/b978-0-12-810532-0.00021-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Seo GH, Kim Y, Oh SH, Chung SJ, Choi IH, Kim G, Yum M, Choi J, Kim KM, Ko T, Lee BH, Yoo H. Biochemical and molecular characterisation of neurological Wilson disease. J Med Genet 2018;55:587-93. [DOI: 10.1136/jmedgenet-2017-105214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Bruha R, Vitek L, Marecek Z, Pospisilova L, Nevsimalova S, Martasek P, Petrtyl J, Urbanek P, Jiraskova A, Malikova I, Haluzik M, Ferenci P. Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. J Inherit Metab Dis 2012;35:541-8. [PMID: 22139496 DOI: 10.1007/s10545-011-9422-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
100 Bayer G, Bauvois A, Mankikian J, Tardieu M, Maillot F, Salame E, Woimant F, Poujois A, Viana M, Legras A. [Ecchymosis as the presenting manifestation of Wilson disease: A case report]. Rev Med Interne 2017;38:416-9. [PMID: 27639912 DOI: 10.1016/j.revmed.2016.08.010] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
101 Xie JJ, Wu ZY. Wilson's Disease in China. Neurosci Bull. 2017;33:323-330. [PMID: 28265897 DOI: 10.1007/s12264-017-0107-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
102 Li XH, Lu Y, Ling Y, Fu QC, Xu J, Zang GQ, Zhou F, De-Min Y, Han Y, Zhang DH. Clinical and molecular characterization of Wilson’s disease in China: identification of 14 novel mutations. BMC Med Genet. 2011;12:6. [PMID: 21219664 DOI: 10.1186/1471-2350-12-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
103 Singh SK, Poddar U, Mishra R, Srivastava A, Yachha SK. Ascitic fluid infection in children with liver disease: time to change empirical antibiotic policy. Hepatol Int 2020;14:138-44. [PMID: 31290071 DOI: 10.1007/s12072-019-09968-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
104 Telinius N, Ott P, Hjortdal J. Detection of Kayser-Fleischer ring using Scheimpflug imaging. Acta Ophthalmol 2017;95:e248-9. [PMID: 27683232 DOI: 10.1111/aos.13271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
105 Sauer V, Siaj R, Stöppeler S, Bahde R, Spiegel HU, Köhler G, Zibert A, Schmidt HH. Repeated transplantation of hepatocytes prevents fulminant hepatitis in a rat model of Wilson's disease. Liver Transpl. 2012;18:248-259. [PMID: 22140056 DOI: 10.1002/lt.22466] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
106 Duncan A, Yacoubian C, Beetham R, Catchpole A, Bullock D. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease. Ann Clin Biochem. 2017;54:649-654. [PMID: 27742851 DOI: 10.1177/0004563216676843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
107 Huong NTM, Lien NTK, Ngoc ND, Mai NTP, Hoa NPA, Hai LT, Van Chi P, Van TT, Van Khanh T, Hoang NH. Three novel mutations in the ATP7B gene of unrelated Vietnamese patients with Wilson disease. BMC Med Genet 2018;19:104. [PMID: 29914392 DOI: 10.1186/s12881-018-0619-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Kim P, Zhang CC, Thoröe-Boveleth S, Weiskirchen S, Gaisa NT, Buhl EM, Stremmel W, Merle U, Weiskirchen R. Accurate Measurement of Copper Overload in an Experimental Model of Wilson Disease by Laser Ablation Inductively Coupled Plasma Mass Spectrometry. Biomedicines 2020;8:E356. [PMID: 32948070 DOI: 10.3390/biomedicines8090356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 García-Villarreal L, Hernández-Ortega A, Sánchez-Monteagudo A, Peña-Quintana L, Ramírez-Lorenzo T, Riaño M, Moreno-Pérez R, Monescillo A, González-Santana D, Quiñones I, Sánchez-Villegas A, Olmo-Quintana V, Garay-Sánchez P, Espinós C, González JM, Tugores A. Wilson disease: revision of diagnostic criteria in a clinical series with great genetic homogeneity. J Gastroenterol 2021;56:78-89. [PMID: 33159804 DOI: 10.1007/s00535-020-01745-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Motamed F, Benabbas R, Ashrafi MR, Aghamohammadi A, Rezaei N. Ataxia-telangiectasia or neurologic Wilson's disease: when strong family history becomes a diagnostic bias. Acta Neurol Belg 2013;113:195-6. [PMID: 22826023 DOI: 10.1007/s13760-012-0117-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
111 Dusek P, Litwin T, Czlonkowska A. Wilson disease and other neurodegenerations with metal accumulations. Neurol Clin. 2015;33:175-204. [PMID: 25432729 DOI: 10.1016/j.ncl.2014.09.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
112 Vieira J, Oliveira PV, Juliano Y, Warde KR, Deguti MM, Barbosa ER, Carrilho FJ, Cancado EL. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease. Dig Liver Dis 2012;44:323-7. [PMID: 22169274 DOI: 10.1016/j.dld.2011.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
113 Kido J, Matsumoto S, Momosaki K, Sakamoto R, Mitsubuchi H, Inomata Y, Endo F, Nakamura K. Plasma exchange and chelator therapy rescues acute liver failure in Wilson disease without liver transplantation. Hepatol Res. 2017;47:359-363. [PMID: 27007780 DOI: 10.1111/hepr.12711] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
114 Ochoa Palominos A, Ibáñez Samaniego L, Catalina Rodríguez MV, Pajares Díaz J, Clemente Ricote G. [Wilson's disease: clinical spectrum of liver disease]. Gastroenterol Hepatol 2013;36:86-91. [PMID: 23089210 DOI: 10.1016/j.gastrohep.2012.07.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Kumar S, Sundaram S, Darak H, Giri S, Bhatia S. Recurrent acute pancreatitis in a Wilson disease patient: an unusual association. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00135-2] [Reference Citation Analysis]
116 Sarode GV, Kim K, Kieffer DA, Shibata NM, Litwin T, Czlonkowska A, Medici V. Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature. Metabolomics 2019;15:43. [PMID: 30868361 DOI: 10.1007/s11306-019-1505-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
117 Yoon JH, Lee JM, Han JK, Choi BI. Shear wave elastography for liver stiffness measurement in clinical sonographic examinations: evaluation of intraobserver reproducibility, technical failure, and unreliable stiffness measurements. J Ultrasound Med. 2014;33:437-447. [PMID: 24567455 DOI: 10.7863/ultra.33.3.437] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 7.9] [Reference Citation Analysis]
118 Gupta S, Rout G, Patel AH, Mahanta M, Kalra N, Sahu P, Sethia R, Agarwal A, Ranjan G, Kedia S, Acharya SK, Nayak B, Shalimar. Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection. J Viral Hepat 2018;25:771-8. [DOI: 10.1111/jvh.12870] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
119 Williams CH, Frush DP. Compendium of national guidelines for imaging of the pediatric patient. Pediatr Radiol 2012;42:82-94. [DOI: 10.1007/s00247-011-2211-3] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
120 Gupta A. Low-density oligonucleotide microarrays - A major step in Wilson's disease diagnosis. Indian J Med Res 2015;141:145-7. [PMID: 25900946 DOI: 10.4103/0971-5916.155534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
121 Munk DE, Björklund J, Lund Laursen T, Vilstrup H, Ott P, Grønbæk H, Damgaard Sandahl T. The galactose elimination capacity test to monitor liver disease course in patients with Wilson's disease. Scand J Gastroenterol 2022;:1-6. [PMID: 34994677 DOI: 10.1080/00365521.2021.2024248] [Reference Citation Analysis]
122 Sensi SL, Granzotto A, Siotto M, Squitti R. Copper and Zinc Dysregulation in Alzheimer's Disease. Trends Pharmacol Sci 2018;39:1049-63. [PMID: 30352697 DOI: 10.1016/j.tips.2018.10.001] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 20.8] [Reference Citation Analysis]
123 Guillaud O, Brunet AS, Mallet I, Dumortier J, Pelosse M, Heissat S, Rivet C, Lachaux A, Bost M. Relative exchangeable copper: A valuable tool for the diagnosis of Wilson disease. Liver Int 2018;38:350-7. [PMID: 28719006 DOI: 10.1111/liv.13520] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
124 Dastsooz H, Imanieh MH, Dehghani SM, Haghighat M, Moini M, Fardaei M. Multiplex ARMS PCR to Detect 8 Common Mutations of ATP7B Gene in Patients With Wilson Disease. Hepat Mon. 2013;13:e8375. [PMID: 24003324 DOI: 10.5812/hepatmon.8375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
125 Wang X, Lin SX, Tao J, Wei XQ, Liu YT, Chen YM, Wu B. Study of liver cirrhosis over ten consecutive years in Southern China. World J Gastroenterol 2014; 20(37): 13546-13555 [PMID: 25309085 DOI: 10.3748/wjg.v20.i37.13546] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
126 Feltracco P, Cagnin A, Carollo C, Barbieri S, Ori C. Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment. Transplantation Reviews 2017;31:193-206. [DOI: 10.1016/j.trre.2017.02.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
127 Hedera P. Wilson's disease: A master of disguise. Parkinsonism & Related Disorders 2019;59:140-5. [DOI: 10.1016/j.parkreldis.2019.02.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
128 Panzer M, Viveiros A, Schaefer B, Baumgartner N, Seppi K, Djamshidian A, Todorov T, Griffiths WJH, Schott E, Schuelke M, Eurich D, Stättermayer AF, Bomford A, Foskett P, Vodopiutz J, Stauber R, Pertler E, Morell B, Tilg H, Müller T, Kiechl S, Jimenez-Heredia R, Weiss KH, Hahn SH, Janecke A, Ferenci P, Zoller H. Synonymous mutation in adenosine triphosphatase copper-transporting beta causes enhanced exon skipping in Wilson disease. Hepatol Commun 2022. [PMID: 35271763 DOI: 10.1002/hep4.1922] [Reference Citation Analysis]
129 Leung M, Wu Lanzafame J, Medici V. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations. J Investig Med High Impact Case Rep 2020;8:2324709619896876. [PMID: 31920114 DOI: 10.1177/2324709619896876] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
130 Doğuizi S, Özateş S, Hoşnut FÖ, Şahin GE, Şekeroğlu MA, Yılmazbaş P. Assessment of corneal and lens clarity in children with Wilson disease. Journal of American Association for Pediatric Ophthalmology and Strabismus 2019;23:147.e1-8. [DOI: 10.1016/j.jaapos.2018.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
131 Güngör Ş, Selimoğlu MA, Varol Fİ, Güngör S. Pediatric Wilson's disease: findings in different presentations. A cross-sectional study. Sao Paulo Med J 2018;136:304-9. [PMID: 30304203 DOI: 10.1590/1516-3180.2018.0210230718] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
132 Weiss KH, Askari FK, Czlonkowska A, Ferenci P, Bronstein JM, Bega D, Ala A, Nicholl D, Flint S, Olsson L, Plitz T, Bjartmar C, Schilsky ML. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study. Lancet Gastroenterol Hepatol. 2017;2:869-876. [PMID: 28988934 DOI: 10.1016/s2468-1253(17)30293-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 24] [Article Influence: 10.4] [Reference Citation Analysis]
133 Weiss KH, Kruse C, Manolaki N, Zuin M, Ferenci P, van Scheppingen D, Wijnberg L, de Koning CE, Dhawan A. Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d-penicillamine. Eur J Gastroenterol Hepatol 2022. [PMID: 35482910 DOI: 10.1097/MEG.0000000000002387] [Reference Citation Analysis]
134 Xie F, Xi Y, Pascual JM, Muzik O, Peng F. Age-dependent changes of cerebral copper metabolism in Atp7b -/- knockout mouse model of Wilson's disease by [64Cu]CuCl2-PET/CT. Metab Brain Dis 2017;32:717-26. [PMID: 28130615 DOI: 10.1007/s11011-017-9956-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
135 Broniek-Kowalik K, Dzieżyc K, Litwin T, Członkowska A, Szaflik JP. Anterior segment optical coherence tomography (AS-OCT) as a new method of detecting copper deposits forming the Kayser-Fleischer ring in patients with Wilson disease. Acta Ophthalmol 2019;97:e757-60. [PMID: 30635971 DOI: 10.1111/aos.14009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
136 Kodama H, Fujisawa C, Bhadhprasit W. Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment. Curr Drug Metab. 2012;13:237-250. [PMID: 21838703 DOI: 10.2174/138920012799320455] [Cited by in Crossref: 101] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
137 Lozano Herrero J, Muñoz Bertrán E, Ortega González I, Gómez Espín R, López Espín MI. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease. Gastroenterología y Hepatología 2012;35:704-7. [DOI: 10.1016/j.gastrohep.2012.03.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
138 Renier N, Reinaud O, Jabin I, Valkenier H. Transmembrane transport of copper(i) by imidazole-functionalised calix[4]arenes. Chem Commun (Camb) 2020;56:8206-9. [PMID: 32555796 DOI: 10.1039/d0cc03555f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
139 James J, Liou IW. Comprehensive Care of Patients with Chronic Liver Disease. Medical Clinics of North America 2015;99:913-33. [DOI: 10.1016/j.mcna.2015.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
140 Lee YH, Park N, Park YB, Hwang YJ, Kang C, Kim JS. Organelle-selective fluorescent Cu2+ ion probes: revealing the endoplasmic reticulum as a reservoir for Cu-overloading. Chem Commun (Camb) 2014;50:3197-200. [PMID: 24519529 DOI: 10.1039/c4cc00091a] [Cited by in Crossref: 82] [Cited by in F6Publishing: 8] [Article Influence: 10.3] [Reference Citation Analysis]
141 Dhakal B, Prabhat K, Karki A, Bhattarai AM, Sapkota S, Subedi B, Dahal A. Late onset Wilson Disease with normal neuro-psychiatric status: A case report. Annals of Medicine and Surgery 2022;77:103678. [DOI: 10.1016/j.amsu.2022.103678] [Reference Citation Analysis]
142 Livingstone C. Review of Copper Provision in the Parenteral Nutrition of Adults. Nutr Clin Pract 2017;32:153-65. [DOI: 10.1177/0884533616673190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
143 Chesi G, Hegde RN, Iacobacci S, Concilli M, Parashuraman S, Festa BP, Polishchuk EV, Di Tullio G, Carissimo A, Montefusco S, Canetti D, Monti M, Amoresano A, Pucci P, van de Sluis B, Lutsenko S, Luini A, Polishchuk RS. Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants. Hepatology 2016;63:1842-59. [PMID: 26660341 DOI: 10.1002/hep.28398] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
144 Muro S, Yasunaka T, Wada N, Morimoto Y, Ikeda F, Shiraha H, Takaki A, Noso K, Iwasaki H, Yamamoto K. A case of Wilson's disease with characteristic laparoscopic findings. Clin J Gastroenterol 2014;7:175-9. [PMID: 26183637 DOI: 10.1007/s12328-014-0465-7] [Reference Citation Analysis]
145 Squitti R, Ghidoni R, Simonelli I, Ivanova ID, Colabufo NA, Zuin M, Benussi L, Binetti G, Cassetta E, Rongioletti M, Siotto M. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators. Journal of Trace Elements in Medicine and Biology 2018;45:181-8. [DOI: 10.1016/j.jtemb.2017.11.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
146 Guttmann S, Bernick F, Naorniakowska M, Michgehl U, Groba SR, Socha P, Zibert A, Schmidt HH. Functional Characterization of Novel ATP7B Variants for Diagnosis of Wilson Disease. Front Pediatr 2018;6:106. [PMID: 29761093 DOI: 10.3389/fped.2018.00106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
147 Wang LC, Wang JD, Tsai CR, Cheng SB, Lin CC. Clinical features and therapeutic response in Taiwanese children with Wilson’s disease: 12 years of experience in a single center. Pediatr Neonatol. 2010;51:124-129. [PMID: 20417464 DOI: 10.1016/s1875-9572(10)60022-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
148 Członkowska A, Litwin T, Chabik G. Wilson disease: neurologic features. Handb Clin Neurol 2017;142:101-19. [PMID: 28433096 DOI: 10.1016/B978-0-444-63625-6.00010-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
149 Tomić A, Dobricić V, Novaković I, Svetel M, Pekmezović T, Kresojević N, Potrebić A, Kostić VS. Mutational analysis of ATP7B gene and the genotype-phenotype correlation in patients with Wilson's disease in Serbia. Vojnosanit Pregl. 2013;70:457-462. [PMID: 23789284 DOI: 10.1007/s12519-012-0388-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
150 Herrera PM, Vélez Van Meerbeke A, Bonnot O. Psychiatric Disorders Secondary to Neurometabolic Disorders. Rev Colomb Psiquiatr (Engl Ed) 2018;47:244-51. [PMID: 30286847 DOI: 10.1016/j.rcp.2017.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
151 Dirksen K, Fieten H. Canine Copper-Associated Hepatitis. Vet Clin North Am Small Anim Pract 2017;47:631-44. [PMID: 28063745 DOI: 10.1016/j.cvsm.2016.11.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
152 Durairaj J, Shanbhag ER, Veena P, Gowda M, Keepanasseril A. Wilson's disease presenting during pregnancy: A diagnostic and therapeutic dilemma. Obstet Med 2018;11:148-50. [PMID: 30214483 DOI: 10.1177/1753495X17743162] [Reference Citation Analysis]
153 M-M P, Weiskirchen R, Gassler N, Bosserhoff AK, Becker JS. Novel bioimaging techniques of metals by laser ablation inductively coupled plasma mass spectrometry for diagnosis of fibrotic and cirrhotic liver disorders. PLoS One 2013;8:e58702. [PMID: 23505552 DOI: 10.1371/journal.pone.0058702] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
154 Seessle J, Gotthardt DN, Schäfer M, Gohdes A, Pfeiffenberger J, Ferenci P, Stremmel W, Weiss KH. Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy. J Inherit Metab Dis 2016;39:125-30. [DOI: 10.1007/s10545-015-9866-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
155 Arciello M, Gori M, Balsano C. Mitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress. Oxid Med Cell Longev. 2013;2013:971024. [PMID: 24371505 DOI: 10.1155/2013/971024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
156 Gomes A, Dedoussis GV. Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol 2016;43:1-8. [PMID: 26207595 DOI: 10.3109/03014460.2015.1051492] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
157 Azova S, Rice T, Garcia-Delgar B, Coffey BJ. New-Onset Psychosis in an Adolescent with Wilson's Disease. J Child Adolesc Psychopharmacol 2016;26:301-4. [PMID: 27097017 DOI: 10.1089/cap.2016.29106.bjc] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
158 Santiago R, Gottrand F, Debray D, Bridoux L, Lachaux A, Morali A, Lapeyre D, Lamireau T. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers. Journal of Pediatric Gastroenterology & Nutrition 2015;61:613-8. [DOI: 10.1097/mpg.0000000000000926] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
159 Flores-Calderón J. [Pediatric hepatology]. Rev Gastroenterol Mex 2013;78 Suppl 1:117-9. [PMID: 24041081 DOI: 10.1016/j.rgmx.2013.06.042] [Reference Citation Analysis]
160 Dalvi A, Padmanaban M. Wilson's disease: etiology, diagnosis, and treatment. Dis Mon. 2014;60:450-459. [PMID: 25234178 DOI: 10.1016/j.disamonth.2014.07.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
161 Ohya Y, Okajima H, Honda M, Hayashida S, Suda H, Matsumoto S, Lee K, Yamamoto H, Takeichi T, Mitsubuchi H, Asonuma K, Endo F, Inomata Y. Re-evaluation of the indications for liver transplantation in Wilson's disease based on the outcomes of patients referred to a transplant center. Pediatric Transplantation 2013;17:369-73. [DOI: 10.1111/petr.12085] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
162 Chaiyo S, Chailapakul O, Sakai T, Teshima N, Siangproh W. Highly sensitive determination of trace copper in food by adsorptive stripping voltammetry in the presence of 1,10-phenanthroline. Talanta 2013;108:1-6. [DOI: 10.1016/j.talanta.2013.02.031] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
163 Rahim MN, Pirani T, Williamson C, Heneghan MA. Management of pregnancy in women with cirrhosis. United European Gastroenterol J 2021;9:110-9. [PMID: 33259738 DOI: 10.1177/2050640620977034] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Pawaria A, Sood V, Lal BB, Khanna R, Bajpai M, Alam S. Ninety days transplant free survival with high volume plasma exchange in Wilson disease presenting as acute liver failure. J Clin Apher. 2021;36:109-117. [PMID: 33368534 DOI: 10.1002/jca.21848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Zhou L, Xiong Y, Wang H, Yin A, Zhang X, Li H, Fu Q, Huang P. Target-triggered DNAzyme walker with 3D walking unit for copper species sensing in serum: A multivalent binding strategy for improving the detection performance. Sensors and Actuators B: Chemical 2021;334:129589. [DOI: 10.1016/j.snb.2021.129589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
166 Saroli Palumbo C, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med 2019;7:S65. [PMID: 31179302 DOI: 10.21037/atm.2018.12.53] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
167 Ware TL, Srinivasan J, Gonzalez L, Hardikar W, Scheinberg AM, Baker L, Prakash C, Ryan MM. Juvenile Parkinsonism: Juvenile Parkinsonism. J Paediatr Child Health 2013;49:409-11. [DOI: 10.1111/j.1440-1754.2012.02555.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
168 Minervino AHH, López-Alonso M, Barrêto Júnior RA, Rodrigues FAML, Araújo CASC, Sousa RS, Mori CS, Miranda M, Oliveira FLC, Antonelli AC, Ortolani EL. Dietary Zinc Supplementation to Prevent Chronic Copper Poisoning in Sheep. Animals (Basel) 2018;8:E227. [PMID: 30513571 DOI: 10.3390/ani8120227] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
169 Riboldi GM, Frucht SJ. Neurologic Manifestations of Systemic Disease: Movement Disorders. Curr Treat Options Neurol 2021;23. [DOI: 10.1007/s11940-020-00659-9] [Reference Citation Analysis]
170 Kogan-Liberman D, Ovchinsky N. 50 Years Ago in TheJournalofPediatrics: Wilson's Disease Remains a Great Masquerader. J Pediatr 2021;231:116. [PMID: 33766291 DOI: 10.1016/j.jpeds.2020.11.037] [Reference Citation Analysis]
171 Malbul K, Katwal S, Khetan S, Aryal N. A case report on serendipitous diagnosis of wilson's disease in a child with brucellosis and pseudomonal infection. Clin Case Rep 2021;9:e04178. [PMID: 34194770 DOI: 10.1002/ccr3.4178] [Reference Citation Analysis]
172 Guindi M. Wilson disease. Semin Diagn Pathol. 2019;36:415-422. [PMID: 31421978 DOI: 10.1053/j.semdp.2019.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
173 Litwin T, Gromadzka G, Członkowska A. Wilson's disease: does iron metabolism impact phenotypic presentation? Liver Int 2012;32:869-70; author reply 870. [PMID: 22292432 DOI: 10.1111/j.1478-3231.2012.02756.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
174 Sidiropoulos C. Reply: bilateral pallidal stimulation for Wilson's disease. Mov Disord 2014;29:1089-90. [PMID: 24797888 DOI: 10.1002/mds.25901] [Reference Citation Analysis]
175 Chandok N, Roberts EA. The trientine crisis in Canada: a call to advocacy. Can J Gastroenterol Hepatol 2014;28:184. [PMID: 24729990 DOI: 10.1155/2014/672809] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
176 Czaja AJ. Cryptogenic chronic hepatitis and its changing guise in adults. Dig Dis Sci. 2011;56:3421-3438. [PMID: 21647651 DOI: 10.1007/s10620-011-1769-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
177 Huang K, Ma K, Hung Y, Lo L, Lin K, Liu P, Hu M, Chueh S. A new copper ionophore DPMQ protects cells against ultraviolet B irradiation by inhibiting the TRPV1 channel. J Cell Physiol 2018;233:9594-610. [DOI: 10.1002/jcp.26861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
178 Chen D, Zhou X, Hou H, Feng L, Liu J, Liang Y, Lin X, Zhang J, Wu C, Liang X, Pei Z, Li X. Clinical efficacy of combined sodium dimercaptopropanesulfonate and zinc treatment in neurological Wilson's disease with D-penicillamine treatment failure. Ther Adv Neurol Disord 2016;9:310-6. [PMID: 27366238 DOI: 10.1177/1756285616641598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
179 Weiskirchen S, Kim P, Weiskirchen R. Laser Ablation Inductively Coupled Plasma Spectrometry: Metal Imaging in Experimental and Clinical Wilson Disease. Inorganics 2019;7:54. [DOI: 10.3390/inorganics7040054] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
180 Mitroiu M, Oude Rengerink K, Pontes C, Sancho A, Vives R, Pesiou S, Fontanet JM, Torres F, Nikolakopoulos S, Pateras K, Rosenkranz G, Posch M, Urach S, Ristl R, Koch A, Loukia S, van der Lee JH, Roes KCB. Applicability and added value of novel methods to improve drug development in rare diseases. Orphanet J Rare Dis 2018;13:200. [PMID: 30419965 DOI: 10.1186/s13023-018-0925-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
181 Denoyer D, Masaldan S, La Fontaine S, Cater MA. Targeting copper in cancer therapy: 'Copper That Cancer'. Metallomics 2015;7:1459-76. [PMID: 26313539 DOI: 10.1039/c5mt00149h] [Cited by in Crossref: 281] [Cited by in F6Publishing: 88] [Article Influence: 40.1] [Reference Citation Analysis]
182 Dong Y, Wang RM, Yang GM, Yu H, Xu WQ, Xie JJ, Zhang Y, Chen YC, Ni W, Wu ZY. Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson's Disease. Clin Gastroenterol Hepatol 2021;19:590-6. [PMID: 32485301 DOI: 10.1016/j.cgh.2020.05.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Sood A, Khurana MS, Mahajan R, Midha V, Puri S, Kaur A, Gupta N, Sharma S. Prevalence and clinical significance of IgA anti-tissue transglutaminase antibodies in patients with chronic liver disease: IgA anti-tTG in cirrhosis. Journal of Gastroenterology and Hepatology 2017;32:446-50. [DOI: 10.1111/jgh.13474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
184 Huang Y, Takatsuki M, Soyama A, Hidaka M, Ono S, Adachi T, Hara T, Okada S, Hamada T, Eguchi S. Living Donor Liver Transplantation for Wilson's Disease Associated with Fulminant Hepatic Failure: A Case Report. Am J Case Rep 2018;19:304-8. [PMID: 29549236 DOI: 10.12659/ajcr.907494] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
185 Al Fadda M, Al Quaiz M, Al Ashgar H, Al Kahtani K, Helmy A, Al Benmousa A, Abdulla M, Peedikayil M. Wilson disease in 71 patients followed for over two decades in a tertiary center in Saudi Arabia: a retrospective review. Ann Saudi Med. 2012;32:623-629. [PMID: 23396027 DOI: 10.5144/0256-4947.2012.623] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
186 Nagral A, Jhaveri A, Nalawade S, Momaya N, Chakkarwar V, Malde P. Kayser-Fleischer rings or bile pigment rings? Indian J Gastroenterol. 2015;34:410-412. [PMID: 26541339 DOI: 10.1007/s12664-015-0603-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
187 Huster D. [Wilson disease]. Internist (Berl) 2018;59:159-74. [PMID: 29340742 DOI: 10.1007/s00108-017-0378-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
188 Pfeiffenberger J, Beinhardt S, Gotthardt DN, Haag N, Freissmuth C, Reuner U, Gauss A, Stremmel W, Schilsky ML, Ferenci P, Weiss KH. Pregnancy in Wilson's disease: Management and outcome. Hepatology 2018;67:1261-9. [PMID: 28859232 DOI: 10.1002/hep.29490] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
189 Raju K, Bangalore GN, Thuruvekere SN, Pathavanalli VN. Wilson's disease: A Clinical autopsy case report with review of literature. J Nat Sci Biol Med 2015;6:248-52. [PMID: 25810676 DOI: 10.4103/0976-9668.149210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
190 Krawczyk M, Müllenbach R, Weber SN, Zimmer V, Lammert F. Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol. 2010;7:669-681. [PMID: 21045792 DOI: 10.1038/nrgastro.2010.170] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
191 Schilsky ML. Transplantation for inherited metabolic disorders of the liver. Transplant Proc 2013;45:455-62. [PMID: 23498779 DOI: 10.1016/j.transproceed.2013.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
192 Agrawal D, Davis B, Quinn A, Thiele D. Should anti-LKM1 be routine for work-up of elevated liver enzymes? Journal of Hepatology 2017;67:417-8. [DOI: 10.1016/j.jhep.2017.03.030] [Reference Citation Analysis]
193 Członkowska A, Litwin T. Treatment of Wilson’s disease – another point of view. Expert Opinion on Orphan Drugs 2015;3:239-43. [DOI: 10.1517/21678707.2015.1016907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
194 Concilli M, Petruzzelli R, Parisi S, Catalano F, Sirci F, Napolitano F, Renda M, Galietta LJV, Di Bernardo D, Polishchuk RS. Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B. Proc Natl Acad Sci U S A 2020;117:32453-63. [PMID: 33288711 DOI: 10.1073/pnas.2006648117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
195 Zanko A, Abrams L. Case report: concurrent Wilson disease and Huntington disease: lightning can strike twice. J Genet Couns 2015;24:40-5. [PMID: 25378206 DOI: 10.1007/s10897-014-9789-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
196 Udompap P, Kim D, Kim WR. Current and Future Burden of Chronic Nonmalignant Liver Disease. Clin Gastroenterol Hepatol. 2015;13:2031-2041. [PMID: 26291665 DOI: 10.1016/j.cgh.2015.08.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 9.9] [Reference Citation Analysis]
197 Quarles CD Jr, Macke M, Michalke B, Zischka H, Karst U, Sullivan P, Field MP. LC-ICP-MS method for the determination of "extractable copper" in serum. Metallomics 2020;12:1348-55. [PMID: 32789408 DOI: 10.1039/d0mt00132e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
198 Devarbhavi H, Singh R, Adarsh CK, Sheth K, Kiran R, Patil M. Factors that predict mortality in children with Wilson disease associated acute liver failure and comparison of Wilson disease specific prognostic indices. J Gastroenterol Hepatol. 2014;29:380-386. [PMID: 24033813 DOI: 10.1111/jgh.12356] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
199 Bayram AK, Gümüş H, Arslan D, Özçora GK, Kumandaş S, Karacabey N, Canpolat M, Per H. Neurological features and management of Wilson disease in children: an evaluation of 12 cases. Turk Pediatri Ars 2016;51:15-21. [PMID: 27103860 DOI: 10.5152/TurkPediatriArs.2016.3080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Schilsky ML. Long-term outcome for Wilson disease: 85% good. Clin Gastroenterol Hepatol 2014;12:690-1. [PMID: 24246766 DOI: 10.1016/j.cgh.2013.11.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
201 Lacombe M, Jaquinod M, Belmudes L, Couté Y, Ramus C, Combes F, Burger T, Mintz E, Barthelon J, Leroy V, Poujois A, Lachaux A, Woimant F, Brun V. Comprehensive and comparative exploration of the Atp7b−/− mouse plasma proteome. Metallomics 2020;12:249-58. [DOI: 10.1039/c9mt00225a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Yu Z, Wu R, Wu M, Zhao L, Li R, Zou H. Preparation of polyamine-functionalized copper specific adsorbents for selective adsorption of copper. Colloids and Surfaces B: Biointerfaces 2010;78:222-8. [DOI: 10.1016/j.colsurfb.2010.03.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
203 Squitti R, Salustri C, Rongioletti M, Siotto M. Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease. Front Neurol 2017;8:503. [PMID: 28993754 DOI: 10.3389/fneur.2017.00503] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
204 Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 2014;59:1144-65. [PMID: 24716201 DOI: 10.1002/hep.26972] [Cited by in Crossref: 512] [Cited by in F6Publishing: 402] [Article Influence: 64.0] [Reference Citation Analysis]
205 Boughammoura S, Ben Mimouna S, Chemek M, Ostertag A, Cohen-Solal M, Messaoudi I. Disruption of Bone Zinc Metabolism during Postnatal Development of Rats after Early Life Exposure to Cadmium. Int J Mol Sci 2020;21:E1218. [PMID: 32059372 DOI: 10.3390/ijms21041218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
206 Zhao K, Wu C, Yao Y, Cao L, Zhang Z, Yuan Y, Wang Y, Pei R, Chen J, Hu X. Ceruloplasmin inhibits the production of extracellular hepatitis B virions by targeting its middle surface protein. J Gen Virol. 2017;98:1410-1421. [PMID: 28678687 DOI: 10.1099/jgv.0.000794] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
207 Ala A, Aliu E, Schilsky ML. Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson disease. Dig Dis Sci 2015;60:1433-9. [PMID: 25605552 DOI: 10.1007/s10620-014-3495-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
208 Zhang Q, He J, Ni W, Lin X, Yao X, Lin M, Murong S, Wang N, Chen W. Noninvasive urine-derived cell lines derived from neurological genetic patients. NeuroReport 2013;24:161-6. [DOI: 10.1097/wnr.0b013e32835e2e44] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
209 Kodama H, Anan Y, Izumi Y, Sato Y, Ogra Y. Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson's disease: a prospective study. BMJ Paediatr Open 2021;5:e000948. [PMID: 34222678 DOI: 10.1136/bmjpo-2020-000948] [Reference Citation Analysis]
210 Schilsky ML. Wilson disease: Clinical manifestations, diagnosis, and treatment. Clin Liver Dis (Hoboken) 2014;3:104-7. [PMID: 30992899 DOI: 10.1002/cld.349] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
211 Shah D. Wilson’s disease: Hepatic manifestations. Disease-a-Month 2014;60:465-74. [DOI: 10.1016/j.disamonth.2014.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
212 El Raziky MS, Ali A, El shahawy A, Hamdy MM. Acute Hemolytic Anemia as an Initial Presentation of Wilson Disease in Children. Journal of Pediatric Hematology/Oncology 2014;36:173-8. [DOI: 10.1097/mph.0000000000000127] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
213 De Fabregues O, Viñas J, Palasí A, Quintana M, Cardona I, Auger C, Vargas V. Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series. Brain Behav 2020;10:e01596. [PMID: 32202078 DOI: 10.1002/brb3.1596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
214 Roberts EA. Wilson's disease. Medicine 2011;39:602-4. [DOI: 10.1016/j.mpmed.2011.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
215 Wenners A, Petko C, von Kaisenberg C, Strauss A, Eckmann-Scholz C, Hoffmann U, Jonat W, Alkatout I. Fetal hypoplastic left heart syndrome and maternal liver transplantation for Wilson's disease: a case report. J Med Case Rep 2013;7:276. [PMID: 24378118 DOI: 10.1186/1752-1947-7-276] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
216 Zhang J, Xiao L, Yang W. Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease. BMC Neurol 2020;20:255. [PMID: 32593295 DOI: 10.1186/s12883-020-01827-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
217 Wooyoung J, Jinwhan C, Joong-seok K, Hee-tae K. Wilson's Disease only Presenting with Isolated Unilateral Resting Tremor. Can J Neurol Sci 2011;38:939-40. [DOI: 10.1017/s0317167100022277] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
218 Woimant F, Trocello J. Disorders of heavy metals. Neurologic Aspects of Systemic Disease Part II. Elsevier; 2014. pp. 851-64. [DOI: 10.1016/b978-0-7020-4087-0.00057-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 4.6] [Reference Citation Analysis]
219 Tai C, Wu J, Chen H, Hsu H, Chang M, Ni Y. Modality of treatment and potential outcome of Wilson disease in Taiwan: A population-based longitudinal study. Journal of the Formosan Medical Association 2018;117:421-6. [DOI: 10.1016/j.jfma.2017.05.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
220 Harada M. Diagnosis for Wilson disease: this disease may not be a rare disease. J Gastroenterol 2021;56:114-5. [PMID: 33392748 DOI: 10.1007/s00535-020-01752-1] [Reference Citation Analysis]
221 Patil M, Sheth KA, Krishnamurthy AC, Devarbhavi H. A review and current perspective on Wilson disease. J Clin Exp Hepatol. 2013;3:321-336. [PMID: 25755520 DOI: 10.1016/j.jceh.2013.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
222 Lee SY, Kim IH, Yoo SH, Kim DG. A Case of Colonic Adenocarcinoma in a Patient with Wilson's Disease. Gut Liver 2013;7:500-3. [PMID: 23898395 DOI: 10.5009/gnl.2013.7.4.500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
223 Xiong Y, Zhou L, Wang H, Li H, Hu Y, Meng P, Zhang X, Huang P. Rapid laboratory diagnosis of Wilson’s disease: One-step simultaneous detection of exchangeable copper and ceruloplasmin in serum based on nanotechnology. Sensors and Actuators B: Chemical 2019;281:713-9. [DOI: 10.1016/j.snb.2018.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
224 Verma N, Pai G, Hari P, Lodha R. Plasma exchange for hemolytic crisis and acute liver failure in Wilson disease. Indian J Pediatr. 2014;81:498-500. [PMID: 23494839 DOI: 10.1007/s12098-013-0979-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
225 Wang M, Phadke M, Packard D, Yadav D, Gorelick F. Zinc: Roles in pancreatic physiology and disease. Pancreatology 2020;20:1413-20. [PMID: 32917512 DOI: 10.1016/j.pan.2020.08.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
226 Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, Herman GE, Hufnagel SB, Klein TE, Korf BR, McKelvey KD, Ormond KE, Richards CS, Vlangos CN, Watson M, Martin CL, Miller DT. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 2017;19:249-55. [PMID: 27854360 DOI: 10.1038/gim.2016.190] [Cited by in Crossref: 910] [Cited by in F6Publishing: 761] [Article Influence: 151.7] [Reference Citation Analysis]
227 Ovchinsky N, Moreira RK, Lefkowitch JH, Lavine JE. Liver biopsy in modern clinical practice: a pediatric point-of-view. Adv Anat Pathol 2012;19:250-62. [PMID: 22692288 DOI: 10.1097/PAP.0b013e31825c6a20] [Cited by in Crossref: 85] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
228 Arnon R, Annunziato R, Schilsky M, Miloh T, Willis A, Sturdevant M, Sakworawich A, Suchy F, Kerkar N. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transplant. 2011;25:E52-E60. [PMID: 20946468 DOI: 10.1111/j.1399-0012.2010.01327.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
229 Gold JI, Gold NB, DeLeon DD, Ganetzky R. Contraceptive use in women with inherited metabolic disorders: a retrospective study and literature review. Orphanet J Rare Dis 2022;17:41. [PMID: 35135572 DOI: 10.1186/s13023-022-02188-x] [Reference Citation Analysis]
230 Dara N, Imanzadeh F, Sayyari AA, Nasri P, Hosseini AH. Simultaneous Presentation of Wilson's Disease and Autoimmune Hepatitis; A Case Report and Review of Literature. Hepat Mon 2015;15:e29043. [PMID: 26288636 DOI: 10.5812/hepatmon.29043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
231 Larson-nath C, Vitola B. Pediatric Acute Liver Failure. Critical Care Clinics 2022;38:301-15. [DOI: 10.1016/j.ccc.2021.11.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Kelly C, Pericleous M. Wilson disease: more than meets the eye. Postgrad Med J 2018;94:335-47. [PMID: 29449431 DOI: 10.1136/postgradmedj-2017-135381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
233 Kalita J, Ranjan A, Misra UK. Oromandibular Dystonia in Wilson's Disease. Mov Disord Clin Pract 2015;2:253-9. [PMID: 30363463 DOI: 10.1002/mdc3.12171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
234 Sood V, Rawat D, Khanna R, Alam S. Cholestatic liver disease masquerading as Wilson disease. Indian J Gastroenterol 2015;34:174-7. [PMID: 25937485 DOI: 10.1007/s12664-015-0552-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
235 Tu HC, Chen HY, Wu CY, Lin PC. Responsive fluorescence enhancement for in vivo Cu(II) monitoring in zebrafish larvae. Biosens Bioelectron 2021;200:113885. [PMID: 34954569 DOI: 10.1016/j.bios.2021.113885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Ranjan A, Kalita J, Kumar S, Bhoi SK, Misra UK. A study of MRI changes in Wilson disease and its correlation with clinical features and outcome. Clin Neurol Neurosurg 2015;138:31-6. [PMID: 26278999 DOI: 10.1016/j.clineuro.2015.07.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
237 Kumar N, Poddar U, Yadav R, Lal H, Pani K, Yachha SK, Srivastava A, Pandey R. Autoimmune Sclerosing Cholangitis in Children: A Prospective Case-Control Study. Pediatr Gastroenterol Hepatol Nutr 2021;24:154-63. [PMID: 33833971 DOI: 10.5223/pghn.2021.24.2.154] [Reference Citation Analysis]
238 Antczak-Kowalska M, Członkowska A, Litwin T, Nehring P, Niewada M, Przybyłkowski A. Gastropathy in patients with Wilson disease. Scand J Gastroenterol 2020;55:14-7. [PMID: 31865812 DOI: 10.1080/00365521.2019.1703035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
239 Członkowska A, Litwin T, Dzieżyc K, Karliński M, Bring J, Bjartmar C. Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson's Disease Rating Scale. BMC Neurol 2018;18:34. [PMID: 29621974 DOI: 10.1186/s12883-018-1039-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
240 Chevalier K, Mauget-faÿsse M, Vasseur V, Azar G, Obadia MA, Poujois A. Eye Involvement in Wilson’s Disease: A Review of the Literature. JCM 2022;11:2528. [DOI: 10.3390/jcm11092528] [Reference Citation Analysis]
241 Dudani K, Solanki RK, Sharma P, Singh D. Adolescent onset Wilson's disease misdiagnosed as psychosis. Indian J Psychiatry 2016;58:480-1. [PMID: 28197013 DOI: 10.4103/0019-5545.196716] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
242 Rabiee A, Hamilton JPA. Pregnancy in Wilson disease. Hepatology 2018;67:1201-3. [PMID: 29077220 DOI: 10.1002/hep.29619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Roberts EA, Herder M, Hollis A. Fair pricing of "old" orphan drugs: considerations for Canada's orphan drug policy. CMAJ 2015;187:422-5. [PMID: 25712953 DOI: 10.1503/cmaj.140308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
244 Chen SJ, Kuo CC, Pan HY, Tsou TC, Yeh SC, Chang JY. Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo. Biochem Pharmacol. 2015;95:28-37. [PMID: 25801007 DOI: 10.1016/j.bcp.2015.03.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
245 Hou H, Chen D, Liu J, Feng L, Zhang J, Liang X, Xu Y, Li X. Zinc monotherapy for young patients with oligosymptomatic Wilson disease: A single center, retrospective study. Clin Res Hepatol Gastroenterol 2021;45:101623. [PMID: 33662781 DOI: 10.1016/j.clinre.2021.101623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
246 Pinto RB, Schneider ACR, Silveira TRD. Cirrhosis in children and adolescents: An overview. World J Hepatol 2015; 7(3): 392-405 [PMID: 25848466 DOI: 10.4254/wjh.v7.i3.392] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
247 Bembenek JP, Kurczych K, Członkowska A. TMS-induced motor evoked potentials in Wilson's disease: a systematic literature review. Bioelectromagnetics 2015;36:255-66. [PMID: 25808411 DOI: 10.1002/bem.21909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
248 Wiernicka A, Dądalski M, Jańczyk W, Kamińska D, Naorniakowska M, Hüsing-kabar A, Schmidt H, Socha P. Early Onset of Wilson Disease: Diagnostic Challenges. Journal of Pediatric Gastroenterology & Nutrition 2017;65:555-60. [DOI: 10.1097/mpg.0000000000001700] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
249 Lachowicz JI, Crespo-alonso M, Caltagirone C, Alberti G, Biesuz R, Orton JO, Nurchi VM. Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies. Journal of Trace Elements in Medicine and Biology 2018;50:580-8. [DOI: 10.1016/j.jtemb.2018.04.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
250 Dusek P, Bahn E, Litwin T, Jabłonka-salach K, Łuciuk A, Huelnhagen T, Madai VI, Dieringer MA, Bulska E, Knauth M, Niendorf T, Sobesky J, Paul F, Schneider SA, Czlonkowska A, Brück W, Wegner C, Wuerfel J. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study. Neuropathol Appl Neurobiol 2017;43:514-32. [DOI: 10.1111/nan.12341] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
251 Xu WQ, Wang RM, Dong Y, Wu ZY. Emerging neurological symptoms after liver transplantation: A 6-year follow-up of an adolescent patient with Wilson's disease. CNS Neurosci Ther 2022. [PMID: 34997703 DOI: 10.1111/cns.13798] [Reference Citation Analysis]
252 Putra J, Ng VL, Perez-Atayde AR. Pediatric Acute Liver Failure: A Clinicopathological Perspective. Pediatr Dev Pathol 2022;:10935266211067893. [PMID: 35356839 DOI: 10.1177/10935266211067893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Vierling JM, Sussman NL. Wilson Disease in Adults. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 165-77. [DOI: 10.1016/b978-0-12-810532-0.00016-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
254 Dzieżyc K, Karliński M, Litwin T, Członkowska A. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients. Eur J Neurol 2014;21:332-7. [PMID: 24313946 DOI: 10.1111/ene.12320] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
255 Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, Mazariegos GV. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology 2014;60:362-98. [PMID: 24782219 DOI: 10.1002/hep.27191] [Cited by in Crossref: 119] [Cited by in F6Publishing: 85] [Article Influence: 14.9] [Reference Citation Analysis]
256 Bruguera M, Abraldes JG. [Common problems in the diagnosis and treatment of Wilson's disease]. Gastroenterol Hepatol. 2013;36:316-325. [PMID: 23570841 DOI: 10.1016/j.gastrohep.2012.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
257 Kim HY, Nam JY, Lee J, Lee HA, Chang Y, Lee HY, Cho H, Lee DH, Cho YY, Cho EJ, Yu SJ, Lee JM, Kim YJ, Yoon J. Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area. Aliment Pharmacol Ther 2018;47:1490-501. [DOI: 10.1111/apt.14623] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
258 Litwin T, Gromadzka G, Samochowiec J, Grzywacz A, Członkowski A, Członkowska A. Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease. JIMD Rep 2013;8:73-80. [PMID: 23430523 DOI: 10.1007/8904_2012_163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
259 Schmidt HH. Role of genotyping in Wilson's disease. J Hepatol. 2009;50:449-452. [PMID: 19118916 DOI: 10.1016/j.jhep.2008.11.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
260 Jang HJ, Kim JM, Choi CY. Elemental analysis of sunflower cataract in Wilson's disease: a study using scanning transmission electron microscopy and energy dispersive spectroscopy. Exp Eye Res 2014;121:58-65. [PMID: 24534570 DOI: 10.1016/j.exer.2014.02.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
261 Kathawala M, Hirschfield GM. Insights into the management of Wilson's disease. Therap Adv Gastroenterol. 2017;10:889-905. [PMID: 29147139 DOI: 10.1177/1756283x17731520] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
262 Heissat S, Harel A, Um K, Brunet AS, Hervieu V, Guillaud O, Dumortier J, Lachaux A, Mintz E, Bost M. Evaluation of the accuracy of exchangeable copper and relative exchangeable copper (REC) in a mouse model of Wilson's disease. J Trace Elem Med Biol 2018;50:652-7. [PMID: 30269758 DOI: 10.1016/j.jtemb.2018.06.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
263 Rojas H. Wilson Disease: What Does Copper Have to Do With It? The Journal for Nurse Practitioners 2022. [DOI: 10.1016/j.nurpra.2022.01.024] [Reference Citation Analysis]
264 Nishimuta M, Masui K, Yamamoto T, Ikarashi Y, Tokushige K, Hashimoto E, Nagashima Y, Shibata N. Copper deposition in oligodendroglial cells in an autopsied case of hepatolenticular degeneration. Neuropathology 2018;38:321-8. [PMID: 29468756 DOI: 10.1111/neup.12456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
265 García Buey L, González Mateos F, Moreno-otero R. Cirrosis hepática. Medicine - Programa de Formación Médica Continuada Acreditado 2012;11:625-33. [DOI: 10.1016/s0304-5412(12)70359-1] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
266 Mi X, Li Z, Yan J, Li Y, Zheng J, Zhuang Z, Yang W, Gong L, Shi J. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models. Biochim Biophys Acta Mol Basis Dis 2020;1866:165842. [PMID: 32446740 DOI: 10.1016/j.bbadis.2020.165842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
267 Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
268 Tezvergil-mutluay A, Carvalho RM, Pashley DH. Hyperzincemia from ingestion of denture adhesives. The Journal of Prosthetic Dentistry 2010;103:380-3. [DOI: 10.1016/s0022-3913(10)60081-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
269 Sobesky R, Guillaud O, Bouzbib C, Sogni P, Poujois A, Woimant F, Duclos-Vallée JC, Bourlière M, de Lédinghen V, Ganne-Carrié N, Bureau C. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF RARE GENETIC LIVER DISEASES. Clin Res Hepatol Gastroenterol 2021;:101768. [PMID: 34332127 DOI: 10.1016/j.clinre.2021.101768] [Reference Citation Analysis]
270 Favre E, Lion-françois L, Canton M, Vanlemmens C, Bonneton M, Bouillet L, Brunet A, Lachaux A. Cognitive Abilities of Children With Neurological and Liver Forms of Wilson Disease. Journal of Pediatric Gastroenterology & Nutrition 2017;64:436-9. [DOI: 10.1097/mpg.0000000000001346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
271 Salatzki J, Mohr I, Heins J, Cerci MH, Ochs A, Paul O, Riffel J, André F, Hirschberg K, Müller-Hennessen M, Giannitsis E, Friedrich MG, Merle U, Weiss KH, Katus HA, Ochs M. The impact of Wilson disease on myocardial tissue and function: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2021;23:84. [PMID: 34162411 DOI: 10.1186/s12968-021-00760-1] [Reference Citation Analysis]
272 Khan HN, Wasim M, Ayesha H, Awan FR. Molecular genetic diagnosis of Wilson disease by ARMS-PCR in a Pakistani family. Mol Biol Rep 2018;45:2585-91. [DOI: 10.1007/s11033-018-4426-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
273 Lucena-Valera A, Perez-Palacios D, Muñoz-Hernandez R, Romero-Gómez M, Ampuero J. Wilson's disease: Revisiting an old friend. World J Hepatol 2021; 13(6): 634-649 [PMID: 34239699 DOI: 10.4254/wjh.v13.i6.634] [Reference Citation Analysis]
274 Sacco A, Martelli F, Pal A, Saraceno C, Benussi L, Ghidoni R, Rongioletti M, Squitti R. Regulatory miRNAs in Cardiovascular and Alzheimer’s Disease: A Focus on Copper. IJMS 2022;23:3327. [DOI: 10.3390/ijms23063327] [Reference Citation Analysis]
275 Kalita J, Kumar V, Ranjan A, Misra UK. Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy. Neuromolecular Med 2015;17:364-72. [PMID: 26224517 DOI: 10.1007/s12017-015-8364-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
276 Ahmad A, Torrazza-Perez E, Schilsky ML. Liver transplantation for Wilson disease. Handb Clin Neurol 2017;142:193-204. [PMID: 28433103 DOI: 10.1016/B978-0-444-63625-6.00016-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
277 Li G, Wu R, Tong R, Bo B, Zhao Y, Gillen KM, Spincemaille P, Ku Y, Du Y, Wang Y, Wang X, Li J. Quantitative Measurement of Metal Accumulation in Brain of Patients With Wilson's Disease. Mov Disord 2020;35:1787-95. [PMID: 32681698 DOI: 10.1002/mds.28141] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
278 Poon KS, Tan KM, Koay ES. Targeted next-generation sequencing of the ATP7B gene for molecular diagnosis of Wilson disease. Clin Biochem 2016;49:166-71. [PMID: 26483271 DOI: 10.1016/j.clinbiochem.2015.10.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
279 Iorio GG, Conforti A, Vallone R, Carbone L, Matarazzo M, De Rosa A, De Rosa P, Picarelli S, Fedele F, Perruolo G, Formisano P, Iorio R, Alviggi C, Di Dato F. Reproductive function of long-term treated patients with hepatic onset of Wilson's disease: a prospective study. Reprod Biomed Online 2021;42:835-41. [PMID: 33549482 DOI: 10.1016/j.rbmo.2020.12.012] [Reference Citation Analysis]
280 Heald CJ, Sarma A, Sachs JR, Zapadka ME, Jewett T, Bunch PM. Practical Genetics for the Neuroradiologist: Adding Value in Neurogenetic Disease. Acad Radiol 2022;29 Suppl 3:S1-S27. [PMID: 33495073 DOI: 10.1016/j.acra.2020.12.021] [Reference Citation Analysis]
281 Zhou X, Xiao X, Li X, Qin H, Pu X, Chen D, Wu C, Feng L, Liang X. A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator. J Neurol 2020;267:1643-50. [DOI: 10.1007/s00415-020-09746-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
282 Gromadzka G, Karpińska A, Przybyłkowski A, Litwin T, Wierzchowska-Ciok A, Dzieżyc K, Chabik G, Członkowska A. Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease. Biometals 2014;27:207-15. [PMID: 24368744 DOI: 10.1007/s10534-013-9694-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
283 Leung M, Aronowitz PB, Medici V. The Present and Future Challenges of Wilson's Disease Diagnosis and Treatment. Clin Liver Dis (Hoboken) 2021;17:267-70. [PMID: 33968387 DOI: 10.1002/cld.1041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
284 Pöhler M, Guttmann S, Nadzemova O, Lenders M, Brand E, Zibert A, Schmidt HH, Sandfort V. CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B. PLoS One 2020;15:e0239411. [PMID: 32997714 DOI: 10.1371/journal.pone.0239411] [Reference Citation Analysis]
285 Li M, Ma J, Wang W, Yang X, Luo K. Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease. BMC Gastroenterol 2021;21:339. [PMID: 34470610 DOI: 10.1186/s12876-021-01911-5] [Reference Citation Analysis]
286 Harada M. Management for acute liver failure of Wilson disease: Indication for liver transplantation. Hepatol Res 2017;47:281-2. [PMID: 27061913 DOI: 10.1111/hepr.12717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
287 Schonfeld EA, Brown RS Jr. Genetic Testing in Liver Disease: What to Order, in Whom, and When. Clin Liver Dis 2017;21:673-86. [PMID: 28987255 DOI: 10.1016/j.cld.2017.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
288 Allocca S, Ciano M, Ciardulli MC, D'Ambrosio C, Scaloni A, Sarnataro D, Caporaso MG, D'Agostino M, Bonatti S. An αB-Crystallin Peptide Rescues Compartmentalization and Trafficking Response to Cu Overload of ATP7B-H1069Q, the Most Frequent Cause of Wilson Disease in the Caucasian Population. Int J Mol Sci 2018;19:E1892. [PMID: 29954118 DOI: 10.3390/ijms19071892] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
289 Zarrilli F, Elce A, Scorza M, Giordano S, Amato F, Castaldo G. An update on laboratory diagnosis of liver inherited diseases. Biomed Res Int 2013;2013:697940. [PMID: 24222913 DOI: 10.1155/2013/697940] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
290 Mirza AC, Panchal SS. Safety evaluation of syringic acid: subacute oral toxicity studies in Wistar rats. Heliyon 2019;5:e02129. [PMID: 31463381 DOI: 10.1016/j.heliyon.2019.e02129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
291 Cheng N, Wang H, Wu W, Yang R, Liu L, Han Y, Guo L, Hu J, Xu L, Zhao J, Han Y, Liu Q, Li K, Wang X, Chen W. Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease. Clin Genet 2017;92:69-79. [PMID: 27982432 DOI: 10.1111/cge.12951] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
292 Weiss KH, Członkowska A, Hedera P, Ferenci P. WTX101 – an investigational drug for the treatment of Wilson disease. Expert Opinion on Investigational Drugs 2018;27:561-7. [DOI: 10.1080/13543784.2018.1482274] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
293 Zheng Z, Xu M, Sun C, Wu Z, Dong Y. Acute-Onset Visual Impairment in Wilson's Disease: A Case Report and Literature Review. Front Neurol 2022;13:911882. [DOI: 10.3389/fneur.2022.911882] [Reference Citation Analysis]
294 Pham LAT, Nguyen TT, Nga Le HB, Tran DQ, Ho CT, Tran TH, Ta VT, Bui TH, Tran VK. Genetic analysis of 55 northern Vietnamese patients with Wilson disease: seven novel mutations in ATP7B. J Genet 2017;96:933-9. [DOI: 10.1007/s12041-017-0857-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
295 Xu MB, Rong PQ, Jin TY, Zhang PP, Liang HY, Zheng GQ. Chinese Herbal Medicine for Wilson's Disease: A Systematic Review and Meta-Analysis. Front Pharmacol 2019;10:277. [PMID: 31001112 DOI: 10.3389/fphar.2019.00277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
296 Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143. [PMID: 33679050 DOI: 10.1016/j.jceh.2020.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
297 Møller LB, Horn N, Jeppesen TD, Vissing J, Wibrand F, Jennum P, Ott P. Clinical presentation and mutations in Danish patients with Wilson disease. Eur J Hum Genet 2011;19:935-41. [PMID: 21610751 DOI: 10.1038/ejhg.2011.80] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
298 Peña-Vélez R, Almanza-Miranda E. [Autoimmune hepatitis in the pediatric age]. Bol Med Hosp Infant Mex 2017;74:324-33. [PMID: 29382475 DOI: 10.1016/j.bmhimx.2017.05.004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
299 Groba SR, Guttmann S, Niemietz C, Bernick F, Sauer V, Hachmöller O, Karst U, Zischka H, Zibert A, Schmidt HH. Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposure. Metallomics 2017;9:1279-87. [PMID: 28805879 DOI: 10.1039/c7mt00189d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Abdel Ghaffar TY, Elsayed SM, Elnaghy S, Shadeed A, Elsobky ES, Schmidt H. Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients. BMC Pediatr. 2011;11:56. [PMID: 21682854 DOI: 10.1186/1471-2431-11-56] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
301 Roy-Chowdhury J, Schilsky ML. Gene therapy of Wilson disease: A "golden" opportunity using rAAV on the 50th anniversary of the discovery of the virus. J Hepatol 2016;64:265-7. [PMID: 26639392 DOI: 10.1016/j.jhep.2015.11.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
302 Liu M, Jin M, Chen X, Wan B, Guo Y, Sheng M, Chen L, Zhao L, Huang D, Li Y. ATP7B Mutation Detection and Pathogenicity Analysis: One Atypical Case of Wilson's Disease with Adrenocortical Insufficiency. J Mol Neurosci 2018;64:20-8. [PMID: 29181760 DOI: 10.1007/s12031-017-0997-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
303 Albrecht P, Müller AK, Ringelstein M, Finis D, Geerling G, Cohn E, Aktas O, Hartung HP, Hefter H, Methner A. Retinal neurodegeneration in Wilson’s disease revealed by spectral domain optical coherence tomography. PLoS One. 2012;7:e49825. [PMID: 23166778 DOI: 10.1371/journal.pone.0049825] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
304 Aggarwal A, Bhatt M. Update on Wilson disease. Int Rev Neurobiol 2013;110:313-48. [PMID: 24209444 DOI: 10.1016/B978-0-12-410502-7.00014-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
305 Trocello JM, Chappuis P, Chaine P, Rémy P, Debray D, Duclos-Vallée JC, Woimant F. [Wilson disease]. Presse Med 2009;38:1089-98. [PMID: 19233606 DOI: 10.1016/j.lpm.2008.11.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
306 Gorini F, Santoro M, Pierini A, Mezzasalma L, Baldacci S, Bargagli E, Boncristiano A, Brunetto MR, Cameli P, Cappelli F, Castaman G, Coco B, Donati MA, Guerrini R, Linari S, Murro V, Olivotto I, Parronchi P, Pochiero F, Rossi O, Scappini B, Sodi A, Vannucchi AM, Coi A. Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study. Front Pharmacol 2022;13:869842. [DOI: 10.3389/fphar.2022.869842] [Reference Citation Analysis]
307 Brewer GJ. Treatment of Wilson’s disease: our patients deserve better. Expert Opinion on Orphan Drugs 2014;2:1245-8. [DOI: 10.1517/21678707.2014.975207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
308 Della Corte C, Mosca A, Vania A, Alterio A, Alisi A, Nobili V. Pediatric liver diseases: current challenges and future perspectives. Expert Rev Gastroenterol Hepatol 2016;10:255-65. [PMID: 26641319 DOI: 10.1586/17474124.2016.1129274] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
309 Cheng T, Yang W, Hao W, Yang Y, Li X, Wei T, Tang L. A colorimetry-impedance dual-mode ceruloplasmin detection strategy based on dendritic mesoporous silicon nanoparticles with CeO2 encapsulation inside and horseradish peroxidase enrichment outside. Sensors and Actuators B: Chemical 2022;355:131312. [DOI: 10.1016/j.snb.2021.131312] [Reference Citation Analysis]
310 Choudhary NS, Saigal S, Saraf N, Rastogi A, Goja S, Bhangui P, Thiagrajan S, Gautam D, Govil D, Vohra V, Soin AS. Outcome of Living Donor Liver Transplantation for Wilson's Disease in Adults: A Single Center Experience. J Clin Exp Hepatol 2018;8:132-5. [PMID: 29892175 DOI: 10.1016/j.jceh.2017.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
311 Mulroy E, Baschieri F, Magrinelli F, Latorre A, Cortelli P, Bhatia KP. Movement Disorders and Liver Disease. Mov Disord Clin Pract 2021;8:828-42. [PMID: 34401403 DOI: 10.1002/mdc3.13238] [Reference Citation Analysis]
312 Chen J, Jiang Y, Shi H, Peng Y, Fan X, Li C. The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Arch 2020;472:1415-29. [PMID: 32506322 DOI: 10.1007/s00424-020-02412-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
313 Borchard S, Bork F, Rieder T, Eberhagen C, Popper B, Lichtmannegger J, Schmitt S, Adamski J, Klingenspor M, Weiss KH, Zischka H. The exceptional sensitivity of brain mitochondria to copper. Toxicol In Vitro 2018;51:11-22. [PMID: 29715505 DOI: 10.1016/j.tiv.2018.04.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
314 Cocoş R, Şendroiu A, Schipor S, Bohîlţea LC, Şendroiu I, Raicu F. Genotype-phenotype correlations in a mountain population community with high prevalence of Wilson's disease: genetic and clinical homogeneity. PLoS One 2014;9:e98520. [PMID: 24897373 DOI: 10.1371/journal.pone.0098520] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
315 Schaefer M, Gotthardt DN, Didion C, Stremmel W, Weiss KH. Increased Prevalence of Subcutaneous Lipomas in Patients With Wilson Disease. Journal of Clinical Gastroenterology 2015;49:e61-3. [DOI: 10.1097/mcg.0000000000000248] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
316 Mayr T, Ferenci P, Weiler M, Fichtner A, Mehrabi A, Hoffmann GF, Mohr I, Pfeiffenberger J, Weiss KH, Teufel-Schäfer U. Optimized Trientine-dihydrochloride Therapy in Pediatric Patients With Wilson Disease: Is Weight-based Dosing Justified? J Pediatr Gastroenterol Nutr 2021;72:115-22. [PMID: 32804908 DOI: 10.1097/MPG.0000000000002902] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Hedera P. Clinical management of Wilson disease. Ann Transl Med 2019;7:S66. [PMID: 31179303 DOI: 10.21037/atm.2019.03.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
318 Takeyama Y, Yokoyama K, Takata K, Tanaka T, Sakurai K, Matsumoto T, Iwashita H, Ueda S, Hirano G, Hanano T, Nakane H, Morihara D, Nishizawa S, Yoshikane M, Anan A, Kakumitsu S, Kitamura Y, Sakamoto M, Irie M, Iwata K, Shakado S, Sohda T, Watanabe H, Hirose S, Hayashi H, Noritomi T, Yamashita Y, Sakisaka S. Clinical features of Wilson disease: Analysis of 10 cases. Hepatol Res 2010;40:1204-11. [PMID: 21040274 DOI: 10.1111/j.1872-034X.2010.00728.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
319 Yahata S, Yung S, Mandai M, Nagahara T, Kuzume D, Sakaeda H, Wakusawa S, Kato A, Tatsumi Y, Kato K, Hayashi H, Isaji R, Sasaki Y, Yano M, Hayashi K, Ishigami M, Goto H. Phenotypes and Chronic Organ Damage May Be Different among Siblings with Wilson's Disease. J Clin Transl Hepatol 2017;5:27-30. [PMID: 28507923 DOI: 10.14218/JCTH.2016.00064] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
320 Li K, Zhang WM, Lin S, Wen L, Wang ZF, Xie D, Wei M, Qiu ZQ, Dai Y, Lin MC. Mutational analysis of ATP7B in north Chinese patients with Wilson disease. J Hum Genet. 2013;58:67-72. [PMID: 23235335 DOI: 10.1038/jhg.2012.134] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
321 Lai CH, Tseng HF. Population-based epidemiologic study of Wilson's disease in Taiwan. Eur J Neurol 2010;17:830-3. [PMID: 20100230 DOI: 10.1111/j.1468-1331.2009.02946.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
322 Wei Z, Huang Y, Liu A, Diao S, Yu Q, Peng Z, Hong M. Mutational characterization of ATP7B gene in 103 Wilson's disease patients from Southern China: identification of three novel mutations. Neuroreport. 2014;25:1075-1080. [PMID: 25089800 DOI: 10.1097/wnr.0000000000000216] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
323 Catana AM, Medici V. Liver transplantation for Wilson disease. World J Hepatol 2012; 4(1): 5-10 [PMID: 22312450 DOI: 10.4254/wjh.v4.i1.5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
324 Bostantjopoulou S, Stathis P, Konitsiotis S. Wilson’s Disease: Neurological Aspects, Clinical Manifestations, and Treatment Considerations. In: Falup-pecurariu C, Ferreira J, Martinez-martin P, Chaudhuri KR, editors. Movement Disorders Curricula. Vienna: Springer; 2017. pp. 343-54. [DOI: 10.1007/978-3-7091-1628-9_33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
325 Weiss KH, Stremmel W. Evolving Perspectives in Wilson Disease: Diagnosis, Treatment and Monitoring. Curr Gastroenterol Rep 2012;14:1-7. [DOI: 10.1007/s11894-011-0227-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
326 Schilsky ML, Honiden S, Arnott L, Emre S. ICU management of acute liver failure. Clin Chest Med. 2009;30:71-87, viii. [PMID: 19186281 DOI: 10.1016/j.ccm.2008.10.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
327 Cai S, Gong JY, Yang J, Wang JS. Anemia following zinc treatment for Wilson's disease: a case report and literature review. BMC Gastroenterol 2019;19:120. [PMID: 31288754 DOI: 10.1186/s12876-019-1038-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
328 Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson’s disease: A review of what we have learned. World J Hepatol 2015; 7(29): 2859-2870 [PMID: 26692151 DOI: 10.4254/wjh.v7.i29.2859] [Cited by in Crossref: 78] [Cited by in F6Publishing: 49] [Article Influence: 11.1] [Reference Citation Analysis]
329 Badenas Orquin C. Avances en el diagnóstico molecular de la enfermedad de Wilson. Gastroenterología y Hepatología 2011;34:428-33. [DOI: 10.1016/j.gastrohep.2011.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
330 Schonfeld EA, Brown RS Jr. Genetic Causes of Liver Disease: When to Suspect a Genetic Etiology, Initial Lab Testing, and the Basics of Management. Med Clin North Am 2019;103:991-1003. [PMID: 31582009 DOI: 10.1016/j.mcna.2019.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
331 Pfaff AR, Beltz J, King E, Ercal N. Medicinal Thiols: Current Status and New Perspectives. Mini Rev Med Chem 2020;20:513-29. [PMID: 31746294 DOI: 10.2174/1389557519666191119144100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
332 Tran TT, Ahn J, Reau NS. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol. 2016;111:176-194; quiz 196. [PMID: 26832651 DOI: 10.1038/ajg.2015.430] [Cited by in Crossref: 100] [Cited by in F6Publishing: 76] [Article Influence: 16.7] [Reference Citation Analysis]
333 Mirza N, Bharadwaj R, Malhotra S, Sibal A. Wilson Disease-Induced Acute Liver Failure (NWI = 13) Salvaged without Liver Transplant by Plasmapheresis. Journal of Child Science 2021;11:e145-7. [DOI: 10.1055/s-0041-1731079] [Reference Citation Analysis]
334 Dubbioso R, Ranucci G, Esposito M, Di Dato F, Topa A, Quarantelli M, Matarazzo M, Santoro L, Manganelli F, Iorio R. Subclinical neurological involvement does not develop if Wilson's disease is treated early. Parkinsonism & Related Disorders 2016;24:15-9. [DOI: 10.1016/j.parkreldis.2016.01.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
335 Tomaszewska E, Dobrowolski P, Kwiecień M. Intestinal Alterations, Basal Hematology, and Biochemical Parameters in Adolescent Rats Fed Different Sources of Dietary Copper. Biol Trace Elem Res 2016;171:185-91. [PMID: 26432448 DOI: 10.1007/s12011-015-0522-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
336 Abdallah MA, Singal AK. Liver Transplantation in Adults With Wilson's Disease for the Neuropsychiatric Phenotype: Are We There Yet? Liver Transpl 2020;26:485-6. [PMID: 32031727 DOI: 10.1002/lt.25727] [Reference Citation Analysis]
337 Nicastro E, Ranucci G, Vajro P, Vegnente A, Iorio R. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 2010;52:1948-56. [PMID: 20967755 DOI: 10.1002/hep.23910] [Cited by in Crossref: 131] [Cited by in F6Publishing: 87] [Article Influence: 10.9] [Reference Citation Analysis]
338 Vetrik M, Mattova J, Mackova H, Kucka J, Pouckova P, Kukackova O, Brus J, Eigner-henke S, Sedlacek O, Sefc L, Stepanek P, Hruby M. Biopolymer strategy for the treatment of Wilson's disease. Journal of Controlled Release 2018;273:131-8. [DOI: 10.1016/j.jconrel.2018.01.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
339 Sánchez-Monteagudo A, Ripollés E, Berenguer M, Espinós C. Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease. Biomedicines 2021;9:1100. [PMID: 34572285 DOI: 10.3390/biomedicines9091100] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
340 Ren C, Shen J, Zeng H. One-Pot Synthesis of Strained Macrocyclic Pyridone Hexamers and Their High Selectivity toward Cu(2+) Recognition. Org Lett 2015;17:5946-9. [PMID: 26640958 DOI: 10.1021/acs.orglett.5b02780] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
341 Telinius N, Ott P, Sandahl T, Hjortdal J. Scheimpflug Imaging of the Danish Cohort of Patients With Wilson Disease. Cornea 2019;38:998-1002. [DOI: 10.1097/ico.0000000000001959] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
342 Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, Schilsky ML. Wilson disease. Nat Rev Dis Primers 2018;4:21. [PMID: 30190489 DOI: 10.1038/s41572-018-0018-3] [Cited by in Crossref: 134] [Cited by in F6Publishing: 120] [Article Influence: 33.5] [Reference Citation Analysis]
343 Kleine RT, Mendes R, Pugliese R, Miura I, Danesi V, Porta G. Wilson's disease: an analysis of 28 Brazilian children. Clinics (Sao Paulo) 2012;67:231-5. [PMID: 22473403 DOI: 10.6061/clinics/2012(03)05] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
344 Almashhrawi AA, Ahmed KT, Rahman RN, Hammoud GM, Ibdah JA. Liver diseases in pregnancy: Diseases not unique to pregnancy. World J Gastroenterol 2013; 19(43): 7630-7638 [PMID: 24282352 DOI: 10.3748/wjg.v19.i43.7630] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
345 Boga S, Ala A, Schilsky ML. Hepatic features of Wilson disease. Handb Clin Neurol. 2017;142:91-99. [PMID: 28433114 DOI: 10.1016/b978-0-444-63625-6.00009-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
346 Treepongkaruna S, Pienvichit P, Phuapradit P, Kodcharin P, Wattanasirichaigoon D. Mutations of ATP7B gene in two Thai siblings with Wilson disease. Asian Biomedicine 2010;4:163-9. [DOI: 10.2478/abm-2010-0020] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
347 Gong G, Jiang L, Lin Q, Liu W, He M, Zhang J, Feng F, Qu W, Xie N. In vivo toxic effects of 4-methoxy-5-hydroxy-canthin-6-one in zebrafish embryos via copper dyshomeostasis and oxidative stress. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2018;204:79-87. [DOI: 10.1016/j.cbpc.2017.11.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
348 Zhou ZH, Wu YF, Yan Y, Liu AQ, Yu QY, Peng ZX, Wang GQ, Hong MF. Persistence with medical treatment for Wilson disease in China based on a single center's survey research. Brain Behav 2021;11:e02168. [PMID: 33949793 DOI: 10.1002/brb3.2168] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
349 Efe C, Ozaslan E, Wahlin S, Purnak T, Muratori L, Quarneti C, Yüksel O, Muratori P. Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study. Liver Int 2013;33:190-6. [DOI: 10.1111/liv.12022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
350 Kwok ML, Chan KM. Functional characterization of copper transporters zCtr1, zAtox1, zAtp7a and zAtp7b in zebrafish liver cell line ZFL. Metallomics 2019;11:1532-46. [DOI: 10.1039/c9mt00159j] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
351 Weiss KH, Thurik F, Gotthardt DN, Schäfer M, Teufel U, Wiegand F, Merle U, Ferenci-Foerster D, Maieron A, Stauber R. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol. 2013;11:1028-35.e1-2. [PMID: 23542331 DOI: 10.1016/j.cgh.2013.03.012] [Cited by in Crossref: 108] [Cited by in F6Publishing: 83] [Article Influence: 12.0] [Reference Citation Analysis]
352 Boaru SG, Merle U, Uerlings R, Zimmermann A, Flechtenmacher C, Willheim C, Eder E, Ferenci P, Stremmel W, Weiskirchen R. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease. J Cell Mol Med 2015;19:806-14. [PMID: 25704483 DOI: 10.1111/jcmm.12497] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
353 Hermann W, Huster D. [Diagnostics of Wilson's disease]. Nervenarzt 2018;89:115-23. [PMID: 29159549 DOI: 10.1007/s00115-017-0452-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
354 Volpert HM, Pfeiffenberger J, Gröner JB, Stremmel W, Gotthardt DN, Schäfer M, Weiss KH, Weiler M. Comparative assessment of clinical rating scales in Wilson's disease. BMC Neurol 2017;17:140. [PMID: 28732478 DOI: 10.1186/s12883-017-0921-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
355 Gupta T, Dhiman RK, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla Y. Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure. J Clin Exp Hepatol 2017;7:9-15. [PMID: 28348465 DOI: 10.1016/j.jceh.2016.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
356 Lytton SD, Osiecki M, Małgorzatawoźniak, Cukrowska B, Wierzbicka A, Goliszek M, Socha P, Janczyk W, Dayanakli D, Abendroth D, Kramp S, Fechner K, Scheper T, Mahler M, Bentow C, Bogdanos D, Fuchs D, Woynarowski M. Tryptophan-kynurenine profile in pediatric autoimmune hepatitis. Immunol Res 2019;67:39-47. [DOI: 10.1007/s12026-019-9068-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
357 Southon A, Burke R, Camakaris J. What can flies tell us about copper homeostasis? Metallomics 2013;5:1346-56. [PMID: 23903872 DOI: 10.1039/c3mt00105a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
358 Schilsky M. Zinc treatment for symptomatic Wilson disease: moving forward by looking back. Hepatology 2009;50:1341-3. [PMID: 19877301 DOI: 10.1002/hep.23355] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
359 Jain V, Poddar U, Negi TS, Saraswat VA, Krishnani N, Yachha SK, Srivastava A. Utility and accuracy of transient elastography in determining liver fibrosis: a case-control study. Eur J Pediatr 2020;179:671-7. [PMID: 31960149 DOI: 10.1007/s00431-019-03561-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
360 Spanu A, Valente M, Langasco I, Leardi R, Orlandoni AM, Ciulu M, Deroma MA, Spano N, Barracu F, Pilo MI, Sanna G. Effect of the irrigation method and genotype on the bioaccumulation of toxic and trace elements in rice. Science of The Total Environment 2020;748:142484. [DOI: 10.1016/j.scitotenv.2020.142484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
361 Masciullo M, Modoni A, Bianchi MLE, De Carolis S, Silvestri G. Positive outcome in a patient with Wilson's disease treated with reduced zinc dosage in pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 2011;159:237-8. [DOI: 10.1016/j.ejogrb.2011.06.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
362 Oe S, Miyagawa K, Honma Y, Harada M. Copper induces hepatocyte injury due to the endoplasmic reticulum stress in cultured cells and patients with Wilson disease. Exp Cell Res 2016;347:192-200. [PMID: 27502587 DOI: 10.1016/j.yexcr.2016.08.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
363 Zarina A, Tolmane I, Krumina Z, Tutane AI, Gailite L. Association of Variants in the CP, ATOX1 and COMMD1 Genes with Wilson Disease Symptoms in Latvia. Balkan J Med Genet 2019;22:37-42. [PMID: 31942415 DOI: 10.2478/bjmg-2019-0023] [Reference Citation Analysis]
364 Lefton HB, Rosa A, Cohen M. Diagnosis and Epidemiology of Cirrhosis. Medical Clinics of North America 2009;93:787-99. [DOI: 10.1016/j.mcna.2009.03.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
365 Vilarinho S, Choi M, Jain D, Malhotra A, Kulkarni S, Pashankar D, Phatak U, Patel M, Bale A, Mane S, Lifton RP, Mistry PK. Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology. J Hepatol 2014;61:1056-63. [PMID: 25016221 DOI: 10.1016/j.jhep.2014.06.038] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
366 Dzieżyc-Jaworska K, Litwin T, Członkowska A. Clinical manifestations of Wilson disease in organs other than the liver and brain. Ann Transl Med 2019;7:S62. [PMID: 31179299 DOI: 10.21037/atm.2019.03.30] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
367 Członkowska A, Litwin T. Wilson disease - currently used anticopper therapy. Handb Clin Neurol 2017;142:181-91. [PMID: 28433101 DOI: 10.1016/B978-0-444-63625-6.00015-X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
368 Ott P, Ala A, Askari FK, Czlonkowska A, Hilgers RD, Poujois A, Roberts EA, Sandahl TD, Weiss KH, Ferenci P, Schilsky ML. Designing Clinical Trials in Wilson's Disease. Hepatology 2021;74:3460-71. [PMID: 34320232 DOI: 10.1002/hep.32074] [Reference Citation Analysis]
369 Ibrahim W. Coexistence of seizure with Wilson's disease: a systematic review. Prog Neurol Psychiatry 2020;24:24-30. [DOI: 10.1002/pnp.559] [Reference Citation Analysis]
370 Mulligan C, Bronstein JM. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020;38:417-432. [PMID: 32279718 DOI: 10.1016/j.ncl.2020.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
371 Poon KS, Teo ZH, Yap JH, Koay ES, Tan K. Challenges in molecular diagnosis of Wilson disease: viewpoint from the clinical laboratory. J Clin Pathol 2020;73:231-4. [PMID: 31796634 DOI: 10.1136/jclinpath-2019-206054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
372 Mocchegiani F, Gemini S, Vincenzi P, Montalti R, Vecchi A, Nicolini D, Federici A, Coletta M, Pansini M, Lanari J, Svegliati Baroni G, Risaliti A, Vivarelli M. Liver transplantation in neurological Wilson's Disease: is there indication? A case report. Transplant Proc 2014;46:2360-4. [PMID: 25242788 DOI: 10.1016/j.transproceed.2014.07.059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
373 Atkinson C, Kamath BM, Mandelcorn J, Cutz E, Raiman JA. Case 2: A teenager with nausea, vomiting and dysarthria. Paediatr Child Health 2013;18:515-7. [PMID: 24497775 DOI: 10.1093/pch/18.10.515a] [Reference Citation Analysis]
374 Jurowski K, Szewczyk B, Nowak G, Piekoszewski W. Biological consequences of zinc deficiency in the pathomechanisms of selected diseases. J Biol Inorg Chem 2014;19:1069-79. [PMID: 24748223 DOI: 10.1007/s00775-014-1139-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
375 Rukunuzzaman M. Wilson's Disease in Bangladeshi Children: Analysis of 100 Cases. Pediatr Gastroenterol Hepatol Nutr 2015;18:121-7. [PMID: 26157698 DOI: 10.5223/pghn.2015.18.2.121] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
376 Ranucci G, Di Dato F, Spagnuolo MI, Vajro P, Iorio R. Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study. Orphanet J Rare Dis 2014;9:41. [PMID: 24661374 DOI: 10.1186/1750-1172-9-41] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
377 Huang L, Yu X, Zhang J, Liu X, Zhang Y, Jiao X, Yu X. Metal Element Excretion in 24-h Urine in Patients with Wilson Disease under Treatment of d-Penicillamine. Biol Trace Elem Res 2012;146:154-9. [DOI: 10.1007/s12011-011-9250-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
378 Qiao L, Ge J, Li C, Liu Y, Hu C, Hu S, Li W, Li T. Pathogenic gene variation spectrum and carrier screening for Wilson's disease in Qingdao area. Mol Genet Genomic Med 2021;9:e1741. [PMID: 34240825 DOI: 10.1002/mgg3.1741] [Reference Citation Analysis]
379 Przybyłkowski A, Szeligowska J, Januszewicz M, Raszeja-wyszomirska J, Szczepankiewicz B, Nehring P, Górnicka B, Litwin T, Członkowska A. Evaluation of liver fibrosis in patients with Wilson’s disease. European Journal of Gastroenterology & Hepatology 2021;33:535-40. [DOI: 10.1097/meg.0000000000001754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
380 Wang Y, Hodgkinson V, Zhu S, Weisman GA, Petris MJ. Advances in the understanding of mammalian copper transporters. Adv Nutr 2011;2:129-37. [PMID: 22332042 DOI: 10.3945/an.110.000273] [Cited by in Crossref: 106] [Cited by in F6Publishing: 94] [Article Influence: 9.6] [Reference Citation Analysis]
381 Litwin T, Dusek P, Skowrońska M, Członkowska A. Treatment of Wilson’s disease – an update. Expert Opinion on Orphan Drugs 2019;7:287-94. [DOI: 10.1080/21678707.2019.1638248] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
382 Di Dato F, Iorio R. Wilson disease: Many guidelines but still many unsolved doubts. Dig Liver Dis 2021;53:139-40. [PMID: 33214062 DOI: 10.1016/j.dld.2020.11.002] [Reference Citation Analysis]
383 Behairy BES, Sira MM, Zalata KR, Salama ESE, Abd-Allah MA. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter? World J Gastroenterol 2016; 22(16): 4238-4249 [PMID: 27122674 DOI: 10.3748/wjg.v22.i16.4238] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
384 Schilsky ML. Acute liver failure and liver assist devices. Transplant Proc 2011;43:879-83. [PMID: 21486619 DOI: 10.1016/j.transproceed.2011.01.109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
385 Zischka H, Borchard S. Mitochondrial Copper Toxicity with a Focus on Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 65-75. [DOI: 10.1016/b978-0-12-810532-0.00008-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
386 Członkowska A, Litwin T, Karliński M, Dziezyc K, Chabik G, Czerska M. D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease. Eur J Neurol 2014;21:599-606. [PMID: 24447648 DOI: 10.1111/ene.12348] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 8.4] [Reference Citation Analysis]
387 Jing R, Han Y, Cheng H, Han Y, Wang K, Weintraub D, Fan Y. Altered large-scale functional brain networks in neurological Wilson's disease. Brain Imaging Behav 2020;14:1445-55. [PMID: 31011947 DOI: 10.1007/s11682-019-00066-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
388 Karp NL, Price ER, Wisner DJ, Chang CB, Hylton NM, Joe BN. Extra-mammary findings on breast MRI: a pictorial review. Clin Imaging 2015;39:547-52. [PMID: 25772531 DOI: 10.1016/j.clinimag.2015.01.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
389 Ferreira CR, Gahl WA. Disorders of metal metabolism. Transl Sci Rare Dis 2017;2:101-39. [PMID: 29354481 DOI: 10.3233/TRD-170015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
390 Valentino PL, Roberts EA, Beer S, Miloh T, Arnon R, Vittorio JM, Schilsky ML. Management of Wilson Disease Diagnosed in Infancy: An Appraisal of Available Experience to Generate Discussion. J Pediatr Gastroenterol Nutr 2020;70:547-54. [PMID: 31899725 DOI: 10.1097/MPG.0000000000002608] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009;49:1017-44. [PMID: 19243014 DOI: 10.1002/hep.22742] [Cited by in Crossref: 1357] [Cited by in F6Publishing: 1134] [Article Influence: 104.4] [Reference Citation Analysis]
392 Resano M, Aramendía M, Rello L, Calvo ML, Bérail S, Pécheyran C. Direct determination of Cu isotope ratios in dried urine spots by means of fs-LA-MC-ICPMS. Potential to diagnose Wilson's disease. J Anal At Spectrom 2013;28:98-106. [DOI: 10.1039/c2ja30262d] [Cited by in Crossref: 41] [Cited by in F6Publishing: 2] [Article Influence: 4.6] [Reference Citation Analysis]
393 Amano T, Matsubara T, Nishida T, Shimakoshi H, Shimoda A, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M. Clinically diagnosed late-onset fulminant Wilson’s disease without cirrhosis: A case report. World J Gastroenterol 2018; 24(2): 290-296 [PMID: 29375214 DOI: 10.3748/wjg.v24.i2.290] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
394 Zhang QJ, Xu LQ, Wang C, Hu W, Wang N, Chen WJ. Four-year follow-up of a Wilson disease pedigree complicated with epilepsy and hypopituitarism: Case report with a literature review. Medicine (Baltimore) 2016;95:e5331. [PMID: 27930511 DOI: 10.1097/MD.0000000000005331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
395 Capone K, Azzam RK. Wilson's Disease: A Review for the General Pediatrician. Pediatr Ann 2018;47:e440-4. [PMID: 30423186 DOI: 10.3928/19382359-20181026-01] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
396 Squitti R, Pal A, Picozza M, Avan A, Ventriglia M, Rongioletti MC, Hoogenraad T. Zinc Therapy in Early Alzheimer's Disease: Safety and Potential Therapeutic Efficacy. Biomolecules 2020;10:E1164. [PMID: 32784855 DOI: 10.3390/biom10081164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
397 Galosi S, Nardecchia F, Leuzzi V. Treatable Inherited Movement Disorders in Children: Spotlight on Clinical and Biochemical Features. Mov Disord Clin Pract 2020;7:154-66. [PMID: 32071932 DOI: 10.1002/mdc3.12897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
398 Proost R, Cassiman D, Levtchenko E, Morava-Kozicz E, Neirynck J, Witters P. Fulminant Wilson Disease in Children: Recovery After Plasma Exchange Without Transplantation. J Pediatr Gastroenterol Nutr 2020;71:720-5. [PMID: 32804913 DOI: 10.1097/MPG.0000000000002894] [Reference Citation Analysis]
399 Jagadisan B, Srivastava A, Yachha SK, Poddar U. Acute on chronic liver disease in children from the developing world: recognition and prognosis. J Pediatr Gastroenterol Nutr 2012;54:77-82. [PMID: 21691224 DOI: 10.1097/MPG.0b013e318228d7da] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
400 Hedera P. Update on the clinical management of Wilson's disease. Appl Clin Genet 2017;10:9-19. [PMID: 28144156 DOI: 10.2147/TACG.S79121] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 7.6] [Reference Citation Analysis]
401 Xu L, Liu Y, Wu H, Wu H, Liu X, Zhou A. Rapid identification of chemical profile in Gandou decoction by UPLC-Q-TOF-MSE coupled with novel informatics UNIFI platform. J Pharm Anal 2020;10:35-48. [PMID: 32123598 DOI: 10.1016/j.jpha.2019.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
402 El-Karaksy H, Fahmy M, El-Raziky MS, El-Hawary M, El-Sayed R, El-Koofy N, El-Mougy F, El-Hennawy A, El-Shabrawi M. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit. Arab J Gastroenterol 2011;12:125-30. [PMID: 22055589 DOI: 10.1016/j.ajg.2011.07.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
403 Di Stefano V, Lionetti E, Rotolo N, La Rosa M, Leonardi S. Hypercalciuria and Nephrocalcinosis as Early Feature of Wilson Disease Onset: Description of a Pediatric Case and Literature Review. Hepat Mon 2012;12. [DOI: 10.5812/hapatmon.6233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
404 Huang C, Fang M, Xiao X, Gao Z, Wang Y, Gao C. Genetic studies discover novel coding and non-coding mutations in patients with Wilson's disease in China. J Clin Lab Anal 2022;:e24459. [PMID: 35470480 DOI: 10.1002/jcla.24459] [Reference Citation Analysis]
405 Page S, Shaik L, Singh R, Rathore SS, Shah K. Neuropsychiatric Atypical Manifestation in Wilson's Disease: A Case Report and Literature Review. Cureus 2020;12:e9290. [PMID: 32832288 DOI: 10.7759/cureus.9290] [Reference Citation Analysis]
406 Hachmöller O, Aichler M, Schwamborn K, Lutz L, Werner M, Sperling M, Walch A, Karst U. Investigating the influence of standard staining procedures on the copper distribution and concentration in Wilson’s disease liver samples by laser ablation-inductively coupled plasma-mass spectrometry. Journal of Trace Elements in Medicine and Biology 2017;44:71-5. [DOI: 10.1016/j.jtemb.2017.06.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
407 Wang J, Zhou Y, Jiang L. Bio-inspired Track-Etched Polymeric Nanochannels: Steady-State Biosensors for Detection of Analytes. ACS Nano 2021;15:18974-9013. [PMID: 34846138 DOI: 10.1021/acsnano.1c08582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
408 Pfister ED. [Wilson's disease : What has been confirmed in diagnostic and therapy?]. Internist (Berl) 2017;58:1233-41. [PMID: 29098318 DOI: 10.1007/s00108-017-0342-9] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
409 Hamilton JP, Koganti L, Muchenditsi A, Pendyala VS, Huso D, Hankin J, Murphy RC, Huster D, Merle U, Mangels C, Yang N, Potter JJ, Mezey E, Lutsenko S. Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) mice. Hepatology 2016;63:1828-41. [PMID: 26679751 DOI: 10.1002/hep.28406] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
410 Ariöz C, Li Y, Wittung-Stafshede P. The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations. Biometals 2017;30:823-40. [PMID: 29063292 DOI: 10.1007/s10534-017-0058-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
411 Pak K, Ordway S, Sadowski B, Canevari M, Torres D. Wilson's Disease and Iron Overload: Pathophysiology and Therapeutic Implications. Clin Liver Dis (Hoboken) 2021;17:61-6. [PMID: 33680437 DOI: 10.1002/cld.986] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
412 Eda K, Mizuochi T, Iwama I, Inui A, Etani Y, Araki M, Hara S, Kumagai H, Hagiwara S, Murayama K, Murakami J, Shimizu N, Kodama H, Yasuda R, Takaki Y, Yamashita Y. Zinc monotherapy for young children with presymptomatic Wilson disease: A multicenter study in Japan: Zinc for pediatric Wilson disease. Journal of Gastroenterology and Hepatology 2018;33:264-9. [DOI: 10.1111/jgh.13812] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
413 Mussi MCL, Nardelli MJ, Santos BC, Abreu ES, Osório FMF, Cançado GGL, Ferrari TCA, Faria LC, Couto CA. Pregnancy Outcomes in Wilson's Disease Women: Single-Center Case Series. Fetal Pediatr Pathol 2021;:1-8. [PMID: 34350816 DOI: 10.1080/15513815.2021.1960940] [Reference Citation Analysis]
414 Nussinson E, Shahbari A, Shibli F, Chervinsky E, Trougouboff P, Markel A. Diagnostic challenges of Wilson’s disease presenting as acute pancreatitis, cholangitis, and jaundice. World J Hepatol 2013; 5(11): 649-653 [PMID: 24303094 DOI: 10.4254/wjh.v5.i11.649] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
415 Bai X, Wang G, Wu L, Liu Y, Cui L, Shi H, Guo L. Deep-gray nuclei susceptibility-weighted imaging filtered phase shift in patients with Wilson's disease. Pediatr Res 2014;75:436-42. [PMID: 24477071 DOI: 10.1038/pr.2013.239] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
416 Xiong Y, Meng P, Li H, Hu Y, Zhou L, Jiang S, Pang Y, Li S, Huang P. Dual signal amplification strategy for high-sensitivity detection of copper species in bio-samples with a tunable dynamic range. Chem Commun 2018;54:2542-5. [DOI: 10.1039/c8cc00189h] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
417 Horn N, Møller LB, Nurchi VM, Aaseth J. Chelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time. J Inorg Biochem 2019;190:98-112. [PMID: 30384011 DOI: 10.1016/j.jinorgbio.2018.10.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
418 Masełbas W, Członkowska A, Litwin T, Niewada M. Persistence with treatment for Wilson disease: a retrospective study. BMC Neurol 2019;19:278. [PMID: 31718567 DOI: 10.1186/s12883-019-1502-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
419 Weiss KH, Runz H, Noe B, Gotthardt DN, Merle U, Ferenci P, Stremmel W, Füllekrug J. Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease. J Inherit Metab Dis 2010;33 Suppl 3:S233-40. [PMID: 20517649 DOI: 10.1007/s10545-010-9123-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
420 Müller JC, Lichtmannegger J, Zischka H, Sperling M, Karst U. High spatial resolution LA-ICP-MS demonstrates massive liver copper depletion in Wilson disease rats upon Methanobactin treatment. J Trace Elem Med Biol 2018;49:119-27. [PMID: 29895360 DOI: 10.1016/j.jtemb.2018.05.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
421 Kuruppu DK, Matthews BR. Young-onset dementia. Semin Neurol 2013;33:365-85. [PMID: 24234358 DOI: 10.1055/s-0033-1359320] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
422 Mufti AR, Reau N. Liver disease in pregnancy. Clin Liver Dis 2012;16:247-69. [PMID: 22541697 DOI: 10.1016/j.cld.2012.03.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
423 Colaci CS, Mendizabal M, Bessone F. Idiosyncratic Drug-Induced Acute Liver Failure: A Challenging and Distressing Scenario. Curr Drug Saf 2019;14:94-101. [PMID: 30767751 DOI: 10.2174/1574886314666190215115434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
424 AlDhaleei W, AlAhmad M, Alhosani I. Wilson's Disease Presenting in Late Adult Life. Case Rep Gastroenterol 2021;15:142-6. [PMID: 33708062 DOI: 10.1159/000512422] [Reference Citation Analysis]
425 Kieffer DA, Medici V. Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence. Liver Res 2017;1:121-30. [PMID: 29270329 DOI: 10.1016/j.livres.2017.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
426 Polishchuk RS. Cellular Function of ATP7B (Wilson ATPase). Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 45-56. [DOI: 10.1016/b978-0-12-810532-0.00006-9] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
427 Braga F, Szőke D, Valente C, Panteghini M. Biologic variation of copper, ceruloplasmin and copper/ceruloplasmin ratio (Cu:Cp) in serum. Clin Chim Acta 2013;415:295-6. [PMID: 23165218 DOI: 10.1016/j.cca.2012.11.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
428 Huster D. Wilson disease. Best Pract Res Clin Gastroenterol. 2010;24:531-539. [PMID: 20955957 DOI: 10.1016/j.bpg.2010.07.014] [Cited by in Crossref: 134] [Cited by in F6Publishing: 116] [Article Influence: 12.2] [Reference Citation Analysis]
429 Seetharaman J, Sarma MS. Chelation therapy in liver diseases of childhood: Current status and response. World J Hepatol 2021; 13(11): 1552-1567 [PMID: 34904029 DOI: 10.4254/wjh.v13.i11.1552] [Reference Citation Analysis]
430 Hachmöller O, Buzanich AG, Aichler M, Radtke M, Dietrich D, Schwamborn K, Lutz L, Werner M, Sperling M, Walch A, Karst U. Elemental bioimaging and speciation analysis for the investigation of Wilson's disease using μXRF and XANES. Metallomics 2016;8:648-53. [DOI: 10.1039/c6mt00001k] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
431 Kaščáková S, Kewish CM, Rouzière S, Schmitt F, Sobesky R, Poupon J, Sandt C, Francou B, Somogyi A, Samuel D, Jacquemin E, Dubart-Kupperschmitt A, Nguyen TH, Bazin D, Duclos-Vallée JC, Guettier C, Le Naour F. Rapid and reliable diagnosis of Wilson disease using X-ray fluorescence. J Pathol Clin Res 2016;2:175-86. [PMID: 27499926 DOI: 10.1002/cjp2.48] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
432 Dathe K, Beck E, Schaefer C. Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database. Reproductive Toxicology 2016;65:39-45. [DOI: 10.1016/j.reprotox.2016.06.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
433 Mazi TA, Shibata NM, Medici V. Lipid and energy metabolism in Wilson disease. Liver Res 2020;4:5-14. [PMID: 32832193 DOI: 10.1016/j.livres.2020.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
434 Vrancken K, Schroeder HJ, Longo LD, Power GG, Blood AB. Role of ceruloplasmin in nitric oxide metabolism in plasma of humans and sheep: a comparison of adults and fetuses. Am J Physiol Regul Integr Comp Physiol 2013;305:R1401-10. [PMID: 24089378 DOI: 10.1152/ajpregu.00266.2013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
435 Wainwright P, Wadey D, Cook P. An inductively coupled plasma mass spectrometry method for relative free copper determination and generation of a paediatric reference interval. Ann Clin Biochem 2018;55:485-90. [DOI: 10.1177/0004563217744809] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
436 Litwin T, Członkowska A, Socha P. Oral Chelator Treatment of Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 357-64. [DOI: 10.1016/b978-0-12-810532-0.00034-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
437 Kim JW, Kim JH, Seo JK, Ko JS, Chang JY, Yang HR, Kang KH. Genetically confirmed Wilson disease in a 9-month old boy with elevations of aminotransferases. World J Hepatol 2013; 5(3): 156-159 [PMID: 23556051 DOI: 10.4254/wjh.v5.i3.156] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
438 Graper ML, Schilsky ML. Patient support groups in the management of Wilson disease. Handb Clin Neurol 2017;142:231-40. [PMID: 28433107 DOI: 10.1016/B978-0-444-63625-6.00020-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
439 Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ, Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version) . World J Gastroenterol 2020; 26(45): 7088-7103 [PMID: 33362370 DOI: 10.3748/wjg.v26.i45.7088] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
440 Yu Z, Sheu Song J, Schmidt B, Corey K, Hawryluk EB. Pediatric Pseudo-pseudoxanthoma Elasticum Resulting From D-Penicillamine Treatment for Wilson Disease. J Pediatr Gastroenterol Nutr 2020;71:731-3. [PMID: 32796424 DOI: 10.1097/MPG.0000000000002888] [Reference Citation Analysis]
441 Wang Y, Xie C, Fu D, Lu L, Lin Y, Dong Q, Wang X, Zheng G. Clinical efficacy and safety of Chinese herbal medicine for Wilson's disease: A systematic review of 9 randomized controlled trials. Complementary Therapies in Medicine 2012;20:143-54. [DOI: 10.1016/j.ctim.2011.12.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
442 Mucha P, Małecka M, Kupcewicz B, Lux K, Dołęga A, Jezierska J, Budzisz E. Copper(II) complexes of 7-amino-2-methylchromone and 7-aminoflavone: Magneto-structural, spectroscopic and DFT characterization. Polyhedron 2018;153:181-96. [DOI: 10.1016/j.poly.2018.07.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
443 Rich AM, Lajoie TM. Wilson's disease--treatment of psychiatric manifestations in pregnancy. Psychosomatics 2012;53:175-7. [PMID: 22424165 DOI: 10.1016/j.psym.2012.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
444 Moores A, Fox S, Lang A, Hirschfield GM. Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting. Can J Gastroenterol 2012;26:333-9. [PMID: 22720274 DOI: 10.1155/2012/123431] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
445 Ismail MS, Hassan M, Martinez-Camacho A, May SB, Goss JA, Kanwal F, Jalal PK. Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades. Transpl Int 2020;33:925-35. [PMID: 32314442 DOI: 10.1111/tri.13622] [Reference Citation Analysis]
446 Masciullo M, Mattogno PP, Modoni A, Silvestri G, De Bonis P. Subdural hematoma in a young woman with an "old" brain. Acta Neurol Belg 2012;112:385-7. [PMID: 22426682 DOI: 10.1007/s13760-012-0054-9] [Reference Citation Analysis]
447 Kumari N, Kathuria R, Srivastav A, Krishnani N, Poddar U, Yachha SK. Significance of histopathological features in differentiating autoimmune liver disease from nonautoimmune chronic liver disease in children. Eur J Gastroenterol Hepatol. 2013;25:333-337. [PMID: 23085577 DOI: 10.1097/meg.0b013e32835a68a1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
448 Mondal S, Ghosh RC, Mukhopadhyaya SK. Studies on the electrolytes and microelements in Wistar rat following multiple exposures to acetamiprid. Toxicol Ind Health 2012;28:422-7. [PMID: 21937532 DOI: 10.1177/0748233711413800] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
449 Kalita J, Kumar V, Misra UK. A Study on Apoptosis and Anti-apoptotic Status in Wilson Disease. Mol Neurobiol 2016;53:6659-67. [PMID: 26646538 DOI: 10.1007/s12035-015-9570-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
450 Li WJ, Chen C, You ZF, Yang RM, Wang XP. Current Drug Managements of Wilson's Disease: From West to East. Curr Neuropharmacol 2016;14:322-5. [PMID: 26639459 DOI: 10.2174/1570159x14666151130222427] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
451 Shandil Y, Dautoo UK, Chauhan GS. New glucosamine Schiff base grafted poly(acrylic acid) as efficient Cu2+ ions adsorbent and antimicrobial agent. Journal of Environmental Chemical Engineering 2018;6:5970-9. [DOI: 10.1016/j.jece.2018.09.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
452 Bruguera M, Jara P, Berenguer M, Mariño Z. [Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease]. Gastroenterol Hepatol 2016;39:571-3. [PMID: 27496807 DOI: 10.1016/j.gastrohep.2016.06.003] [Reference Citation Analysis]
453 Rodríguez-quiroga SA, Rosales J, Arakaki T, Cordoba M, González-morón D, Medina N, Garretto NS, Kauffman MA. Timely diagnosis of Wilson's disease using whole exome sequencing. Parkinsonism & Related Disorders 2015;21:1375-7. [DOI: 10.1016/j.parkreldis.2015.09.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
454 Poujois A, Trocello JM, Djebrani-Oussedik N, Poupon J, Collet C, Girardot-Tinant N, Sobesky R, Habès D, Debray D, Vanlemmens C, Fluchère F, Ory-Magne F, Labreuche J, Preda C, Woimant F. Exchangeable copper: a reflection of the neurological severity in Wilson's disease. Eur J Neurol 2017;24:154-60. [PMID: 27739240 DOI: 10.1111/ene.13171] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
455 Barber RG, Grenier ZA, Burkhead JL. Copper Toxicity Is Not Just Oxidative Damage: Zinc Systems and Insight from Wilson Disease. Biomedicines 2021;9:316. [PMID: 33804693 DOI: 10.3390/biomedicines9030316] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
456 Weiskirchen S, Kim P, Weiskirchen R. Determination of copper poisoning in Wilson's disease using laser ablation inductively coupled plasma mass spectrometry. Ann Transl Med 2019;7:S72. [PMID: 31179309 DOI: 10.21037/atm.2018.10.67] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
457 Squitti R, Cerchiaro G, Giovannoni I, Francalanci P, Siotto M, Maffei P, Ricordi C, Rongioletti MC. A case of a mild Wolfram Syndrome with concomitant ATP7B mutation. CellR4 Repair Replace Regen Reprogram 2019;7:e2735. [PMID: 33869661 DOI: 10.32113/cellr4_20198_2735] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
458 Bekele N, Ewnetu F, Hailu T, Tegegne Z, Tadesse A. Wilson's Disease: Diagnosis of Wilson's Disease in Ethiopian Young Sisters. Case Rep Med 2020;2020:7650170. [PMID: 32774387 DOI: 10.1155/2020/7650170] [Reference Citation Analysis]
459 Squires JE, McKiernan P. Molecular Mechanisms in Pediatric Cholestasis. Gastroenterol Clin North Am. 2018;47:921-937. [PMID: 30337041 DOI: 10.1016/j.gtc.2018.07.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
460 Lohe VK, Kadu RP, Degwekar SS, Bhowate RR, Wanjari AK, Dangore SB. Dental considerations in the patient with Wilson's disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:20-3. [PMID: 21176821 DOI: 10.1016/j.tripleo.2010.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
461 Aggarwal A, Bhatt M. Neurological Wilson Disease. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 195-214. [DOI: 10.1016/b978-0-12-810532-0.00018-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
462 Li DL, Liu BR. A review of differences in cirrhosis between men and women and characteristics of cirrhosis in females. Shijie Huaren Xiaohua Zazhi 2015; 23(11): 1763-1769 [DOI: 10.11569/wcjd.v23.i11.1763] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
463 Wattacheril J, Shea PR, Mohammad S, Behling C, Aggarwal V, Wilson LA, Yates KP, Ito J, Fishbein M, Stong N, Lavine JE, Goldstein DB. Exome sequencing of an adolescent with nonalcoholic fatty liver disease identifies a clinically actionable case of Wilson disease. Cold Spring Harb Mol Case Stud 2018;4:a003087. [PMID: 30026388 DOI: 10.1101/mcs.a003087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
464 Vandriel SM, Ayoub MD, Ricciuto A, Hansen BE, Ling SC, Ng VL, Roberts EA, Kamath BM. Pediatric Wilson Disease Presenting as Acute Liver Failure: An Individual Patient Data Meta-analysis. Journal of Pediatric Gastroenterology & Nutrition 2020;71:e90-6. [DOI: 10.1097/mpg.0000000000002777] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
465 Lee A, Sarva H. Approach to Tremor Disorders. Semin Neurol 2021;41:731-43. [PMID: 34826875 DOI: 10.1055/s-0041-1726356] [Reference Citation Analysis]
466 Moscoso CG, Steer CJ. "Let my liver rather heat with wine" - a review of hepatic fibrosis pathophysiology and emerging therapeutics. Hepat Med 2019;11:109-29. [PMID: 31565001 DOI: 10.2147/HMER.S213397] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
467 Langwińska-Wośko E, Litwin T, Szulborski K, Członkowska A. Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson's disease. Metab Brain Dis 2016;31:405-15. [PMID: 26686677 DOI: 10.1007/s11011-015-9776-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
468 Han Y, Zhang F, Tian Y, Hu P, Li B, Wang K. Selective impairment of attentional networks of alerting in Wilson's disease. PLoS One 2014;9:e100454. [PMID: 24949936 DOI: 10.1371/journal.pone.0100454] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
469 Kumar T, Thakar A. Ayurvedic approach for management of Wilson's disease: A case report. J Ayurveda Integr Med 2020;11:177-80. [PMID: 32044225 DOI: 10.1016/j.jaim.2019.09.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
470 Langley A, Dameron CT. Copper and anesthesia: clinical relevance and management of copper related disorders. Anesthesiol Res Pract 2013;2013:750901. [PMID: 23762044 DOI: 10.1155/2013/750901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
471 Brunet A, Marotte S, Guillaud O, Lachaux A. Familial screening in Wilson’s disease: Think at the previous generation! Journal of Hepatology 2012;57:1394-5. [DOI: 10.1016/j.jhep.2012.07.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
472 Omeish H, Hajjaj N, Abdulelah M, Bader H. You Only Find What You Are Looking for: Concurrent Alcoholic Liver Cirrhosis and Undiagnosed Wilson's Disease. Cureus 2021;13:e17117. [PMID: 34527496 DOI: 10.7759/cureus.17117] [Reference Citation Analysis]
473 Aggarwal A, Bhatt M. The Pragmatic Treatment of Wilson's Disease. Mov Disord Clin Pract 2014;1:14-23. [PMID: 30363895 DOI: 10.1002/mdc3.12003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
474 Wu X, Leegwater PA, Fieten H. Canine Models for Copper Homeostasis Disorders. Int J Mol Sci 2016;17:196. [PMID: 26861285 DOI: 10.3390/ijms17020196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
475 Kalita J, Kumar V, Misra UK, Kumar S. Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury. J Mol Neurosci 2021;71:338-46. [DOI: 10.1007/s12031-020-01654-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
476 Ferenci P, Litwin T, Seniow J, Czlonkowska A. Encephalopathy in Wilson disease: copper toxicity or liver failure? J Clin Exp Hepatol 2015;5:S88-95. [PMID: 26041965 DOI: 10.1016/j.jceh.2014.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
477 Siotto M, Squitti R. Copper imbalance in Alzheimer’s disease: Overview of the exchangeable copper component in plasma and the intriguing role albumin plays. Coordination Chemistry Reviews 2018;371:86-95. [DOI: 10.1016/j.ccr.2018.05.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
478 Quaglia A, Roberts EA, Torbenson M. Developmental and Inherited Liver Disease. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 111-274. [DOI: 10.1016/b978-0-7020-6697-9.00003-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
479 Bhavsar AS, Verma S, Lamba R, Lall CG, Koenigsknecht V, Rajesh A. Abdominal manifestations of neurologic disorders. Radiographics 2013;33:135-53. [PMID: 23322834 DOI: 10.1148/rg.331125097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
480 Metsla K, Kirss S, Laks K, Sildnik G, Palgi M, Palumaa T, Tõugu V, Palumaa P. α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease. J Alzheimers Dis 2021. [PMID: 34864665 DOI: 10.3233/JAD-215026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
481 Schilsky ML, Roberts EA, Hahn S, Askari F. Costly choices for treating Wilson's disease. Hepatology 2015;61:1106-8. [PMID: 25524500 DOI: 10.1002/hep.27663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
482 Zischka H, Lichtmannegger J. Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models: Mitochondrial copper in WD. Ann N Y Acad Sci 2014;1315:6-15. [DOI: 10.1111/nyas.12347] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
483 Stremmel W, Longerich T, Liere R, Vacata V, van Helden J, Weiskirchen R. Wilson disease — the impact of hyperimmunity on disease activity: A case report. World J Clin Cases 2021; 9(6): 1386-1393 [PMID: 33644206 DOI: 10.12998/wjcc.v9.i6.1386] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
484 Dzieżyc K, Litwin T, Chabik G, Członkowska A. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease. Funct Neurol 2015;30:264-8. [PMID: 26727705 DOI: 10.11138/fneur/2015.30.4.264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
485 Pitman SK, Huynh T, Bjarnason TA, An J, Malkhasyan KA. A case report and focused literature review of d-penicillamine and severe neutropenia: A serious toxicity from a seldom-used drug. Clin Case Rep 2019;7:990-4. [PMID: 31110732 DOI: 10.1002/ccr3.2125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
486 Tian Y, Gong GZ, Yang X, Peng F. Diagnosis and management of fulminant Wilson's disease: a single center's experience. World J Pediatr. 2016;12:209-214. [PMID: 26041495 DOI: 10.1007/s12519-015-0026-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
487 Dzieżyc K, Litwin T, Chabik G, Członkowska A. Frequencies of initial gait disturbances and falls in 100 Wilson's disease patients. Gait & Posture 2015;42:601-3. [DOI: 10.1016/j.gaitpost.2015.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
488 Durankuş F, Albayrak Y, Tokgöz Y, Beşer ÖF, Durankuş R, Çam S, Sünnetçi E, Akarsu Ö, Nural C, Erel Ö. Investigation of Thiol/Disulfide Homeostasis and Ischemia-Modified Albumin Levels in Children with Wilson Disease. Fetal Pediatr Pathol 2021;:1-10. [PMID: 33945395 DOI: 10.1080/15513815.2021.1918298] [Reference Citation Analysis]
489 Buijink AW, Contarino MF, Koelman JH, Speelman JD, van Rootselaar AF. How to tackle tremor - systematic review of the literature and diagnostic work-up. Front Neurol 2012;3:146. [PMID: 23109928 DOI: 10.3389/fneur.2012.00146] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
490 El Balkhi S, Trocello JM, Poupon J, Chappuis P, Massicot F, Girardot-Tinant N, Woimant F. Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis. Clin Chim Acta. 2011;412:2254-2260. [PMID: 21878323 DOI: 10.1016/j.cca.2011.08.019] [Cited by in Crossref: 77] [Cited by in F6Publishing: 56] [Article Influence: 7.0] [Reference Citation Analysis]
491 You S, Rong Y, Zhu B, Zhang A, Zang H, Liu H, Li D, Wan Z, Xin S. Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey. Hepatol Int. 2013;7:714-720. [PMID: 26201805 DOI: 10.1007/s12072-013-9424-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
492 Polishchuk EV, Merolla A, Lichtmannegger J, Romano A, Indrieri A, Ilyechova EY, Concilli M, De Cegli R, Crispino R, Mariniello M, Petruzzelli R, Ranucci G, Iorio R, Pietrocola F, Einer C, Borchard S, Zibert A, Schmidt HH, Di Schiavi E, Puchkova LV, Franco B, Kroemer G, Zischka H, Polishchuk RS. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis. Gastroenterology 2019; 156: 1173-1189. e5. [PMID: 30452922 DOI: 10.1053/j.gastro.2018.11.032] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
493 Rakshit A, Khatua K, Shanbhag V, Comba P, Datta A. Cu2+ selective chelators relieve copper-induced oxidative stress in vivo. Chem Sci 2018;9:7916-30. [PMID: 30450181 DOI: 10.1039/c8sc04041a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
494 Annu A, Mohit B. Importance of adequate decoppering in Wilson's disease. Mov Disord 2014;29:1089-1089. [DOI: 10.1002/mds.25900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
495 Aggarwal A, Chandhok G, Todorov T, Parekh S, Tilve S, Zibert A, Bhatt M, Schmidt HH. Wilson disease mutation pattern with genotype-phenotype correlations from Western India: confirmation of p.C271* as a common Indian mutation and identification of 14 novel mutations. Ann Hum Genet. 2013;77:299-307. [PMID: 23551039 DOI: 10.1111/ahg.12024] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
496 Harada M. Pathogenesis and management of Wilson disease: Wilson disease. Hepatol Res 2014;44:395-402. [DOI: 10.1111/hepr.12301] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
497 Ma K, Berger D, Reau N. Liver Diseases During Pregnancy. Clin Liver Dis 2019;23:345-61. [PMID: 30947881 DOI: 10.1016/j.cld.2018.12.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
498 Walter U, Skowrońska M, Litwin T, Szpak GM, Jabłonka-Salach K, Skoloudík D, Bulska E, Członkowska A. Lenticular nucleus hyperechogenicity in Wilson's disease reflects local copper, but not iron accumulation. J Neural Transm (Vienna) 2014;121:1273-9. [PMID: 24615184 DOI: 10.1007/s00702-014-1184-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
499 Roberts EA, Socha P. Wilson disease in children. Handb Clin Neurol. 2017;142:141-156. [PMID: 28433098 DOI: 10.1016/b978-0-444-63625-6.00012-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
500 Kim SJ, Han HH, Hahn SK. Hyaluronate/black phosphorus complexes as a copper chelating agent for Wilson disease treatment. Biomater Res 2021;25:20. [PMID: 34134773 DOI: 10.1186/s40824-021-00221-x] [Reference Citation Analysis]
501 Mohr I, Weiss KH. Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. Clin Biochem Rev 2019;40:59-77. [PMID: 31205375 DOI: 10.33176/AACB-18-00014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 6.7] [Reference Citation Analysis]
502 Mladěnka P, Karlíčková J, Hrubša M, Veljović E, Muratović S, Carazo A, Shivling Mali A, Špirtović-halilović S, Saso L, Pour M, Durić K. Interaction of 2,6,7-Trihydroxy-Xanthene-3-Ones with Iron and Copper, and Biological Effect of the Most Active Derivative on Breast Cancer Cells and Erythrocytes. Applied Sciences 2020;10:4846. [DOI: 10.3390/app10144846] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
503 Xu L, Liu Y, Wu H, Zhou A. Rapid identification of absorbed components and metabolites of Gandou decoction in rat plasma and liver by UPLC-Q-TOF-MSE. Journal of Chromatography B 2020;1137:121934. [DOI: 10.1016/j.jchromb.2019.121934] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
504 Katayama K, Saito M, Kawaguchi T, Endo R, Sawara K, Nishiguchi S, Kato A, Kohgo H, Suzuki K, Sakaida I, Ueno Y, Habu D, Ito T, Moriwaki H, Suzuki K. Effect of zinc on liver cirrhosis with hyperammonemia: a preliminary randomized, placebo-controlled double-blind trial. Nutrition. 2014;30:1409-1414. [PMID: 25280421 DOI: 10.1016/j.nut.2014.04.018] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
505 Shahandeh A, Bui BV, Finkelstein DI, Nguyen CTO. Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina. J Neurosci Res 2020;98:1889-904. [DOI: 10.1002/jnr.24685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
506 Dal MB, Alim A, Acarli K. The advantage of early liver transplantation for Wilson's disease using living donors. Prz Gastroenterol 2021;16:213-8. [PMID: 34584582 DOI: 10.5114/pg.2021.108990] [Reference Citation Analysis]
507 Squitti R, Ventriglia M, Simonelli I, Bonvicini C, Costa A, Perini G, Binetti G, Benussi L, Ghidoni R, Koch G, Borroni B, Albanese A, Sensi SL, Rongioletti M. Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants. Biomolecules 2021;11:960. [PMID: 34209820 DOI: 10.3390/biom11070960] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
508 Liggi M, Murgia D, Civolani A, Demelia E, Sorbello O, Demelia L. The relationship between copper and steatosis in Wilson’s disease. Clin Res Hepatol Gastroenterol. 2013;37:36-40. [PMID: 22572525 DOI: 10.1016/j.clinre.2012.03.038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
509 Hueting R. Radiocopper for the imaging of copper metabolism: Radiocopper for the imaging of copper metabolism. J Label Compd Radiopharm 2014;57:231-8. [DOI: 10.1002/jlcr.3155] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
510 Schaefer M, Gotthardt DN, Ganion N, Wohnsland S, Seessle J, Stremmel W, Pfeiffenberger J, Weiss KH. Wilson disease: Health-related quality of life and risk for depression. Clinics and Research in Hepatology and Gastroenterology 2016;40:349-56. [DOI: 10.1016/j.clinre.2015.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
511 Lynch EN, Campani C, Innocenti T, Dragoni G, Forte P, Galli A. Practical insights into chronic management of hepatic Wilson’s disease. World J Clin Cases 2022; 10(14): 4334-4347 [DOI: 10.12998/wjcc.v10.i14.4334] [Reference Citation Analysis]
512 Boga S, Jain D, Schilsky ML. Trientine induced colitis during therapy for Wilson disease: a case report and review of the literature. BMC Pharmacol Toxicol 2015;16:30. [PMID: 26589720 DOI: 10.1186/s40360-015-0031-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
513 Dahmoush HM, Melhem ER, Vossough A. Metabolic, endocrine, and other genetic disorders. Neuroimaging Part II. Elsevier; 2016. pp. 1221-59. [DOI: 10.1016/b978-0-444-53486-6.00063-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
514 Smirnova J, Kabin E, Järving I, Bragina O, Tõugu V, Plitz T, Palumaa P. Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent. Sci Rep 2018;8:1463. [PMID: 29362485 DOI: 10.1038/s41598-018-19873-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
515 Walker LR, Rattigan M, Canterino J. A case of isolated elevated copper levels during pregnancy. J Pregnancy 2011;2011:385767. [PMID: 21773030 DOI: 10.1155/2011/385767] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
516 Hachmöller O, Aichler M, Schwamborn K, Lutz L, Werner M, Sperling M, Walch A, Karst U. Element bioimaging of liver needle biopsy specimens from patients with Wilson’s disease by laser ablation-inductively coupled plasma-mass spectrometry. Journal of Trace Elements in Medicine and Biology 2016;35:97-102. [DOI: 10.1016/j.jtemb.2016.02.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
517 Dong Y, Shi SS, Chen S, Ni W, Zhu M, Wu ZY. The discrepancy between the absence of copper deposition and the presence of neuronal damage in the brain of Atp7b(-/-) mice. Metallomics 2015;7:283-8. [PMID: 25594375 DOI: 10.1039/c4mt00242c] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
518 Rosenblatt R, Brown RS. Nonviral or Drug-Induced Etiologies of Acute Liver Failure. Clinics in Liver Disease 2018;22:347-60. [DOI: 10.1016/j.cld.2018.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
519 Dzieżyc K, Litwin T, Członkowska A. Other organ involvement and clinical aspects of Wilson disease. Handb Clin Neurol 2017;142:157-69. [PMID: 28433099 DOI: 10.1016/B978-0-444-63625-6.00013-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
520 Albright CM, Fay EE. Chronic Liver Disease in the Obstetric Patient. Clin Obstet Gynecol 2020;63:193-210. [PMID: 31789831 DOI: 10.1097/GRF.0000000000000502] [Reference Citation Analysis]
521 Cleymaet S, Nagayoshi K, Gettings E, Faden J. A review and update on the diagnosis and treatment of neuropsychiatric Wilson disease. Expert Review of Neurotherapeutics 2019;19:1117-26. [DOI: 10.1080/14737175.2019.1645009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
522 Pfeiffenberger J, Kruse C, Mutch P, Harker A, Weiss KH. The steady state pharmacokinetics of trientine in Wilson disease patients. Eur J Clin Pharmacol 2018;74:731-6. [PMID: 29417175 DOI: 10.1007/s00228-018-2424-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
523 Bale A, Pai CG, Shetty S, Balaraju G, Shetty A. Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver. J Clin Exp Hepatol 2018;8:156-61. [PMID: 29892178 DOI: 10.1016/j.jceh.2017.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
524 Walshe JM. Monitoring copper in Wilson's disease. Adv Clin Chem 2010;50:151-63. [PMID: 20521445 DOI: 10.1016/s0065-2423(10)50008-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
525 Pfeiffer RF. Wilson's disease. Handb Clin Neurol 2011;100:681-709. [PMID: 21496616 DOI: 10.1016/B978-0-444-52014-2.00049-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
526 Leung KP, Chen D, Chan KM. Understanding copper sensitivity in zebrafish (Danio rerio) through the intracellular localization of copper transporters in a hepatocyte cell-line ZFL and the tissue expression profiles of copper transporters. Metallomics 2014;6:1057-67. [PMID: 24658744 DOI: 10.1039/c3mt00366c] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
527 Ma H, Lv X, Han Y, Zhang F, Ye R, Yu F, Han Y, Schiebener J, Wang K. Decision-making impairments in patients with Wilson's disease. Journal of Clinical and Experimental Neuropsychology 2013;35:472-9. [DOI: 10.1080/13803395.2013.789486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
528 Lutfi R, Abulebda K, Nitu ME, Molleston JP, Bozic MA, Subbarao G. Intensive Care Management of Pediatric Acute Liver Failure. J Pediatr Gastroenterol Nutr. 2017;64:660-670. [PMID: 27741059 DOI: 10.1097/mpg.0000000000001441] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
529 Grolmusová Z, Horňáčková M, Plavčan J, Kopáni M, Babál P, Veis P. Laser induced breakdown spectroscopy of human liver samples with Wilson’s disease. Eur Phys J Appl Phys 2013;63:20801. [DOI: 10.1051/epjap/2013130030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
530 Merle U, Eisenbach C, Weiss KH, Tuma S, Stremmel W. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson’s disease. J Hepatol. 2009;51:925-930. [PMID: 19720421 DOI: 10.1016/j.jhep.2009.06.022] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
531 Sammons S, Brady D, Vahdat L, Salama AK. Copper suppression as cancer therapy: the rationale for copper chelating agents in BRAFV600 mutated melanoma. Melanoma Manag 2016;3:207-16. [PMID: 30190890 DOI: 10.2217/mmt-2015-0005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
532 Yan YQ, Zheng ZY, Zeng DH, Liu QH, Zhu YL, Zheng QL, Qu LJ. Clinicopathologic features of Wilson disease of the liver. Shijie Huaren Xiaohua Zazhi 2016; 24(5): 782-789 [DOI: 10.11569/wcjd.v24.i5.782] [Reference Citation Analysis]
533 Chang IJ, Hahn SH. The genetics of Wilson disease. 1st ed. Elsevier. 2017;. [PMID: 28433102 DOI: 10.1016/b978-0-444-63625-6.00003-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 11.8] [Reference Citation Analysis]
534 Cope-Yokoyama S, Finegold MJ, Sturniolo GC, Kim K, Mescoli C, Rugge M, Medici V. Wilson disease: Histopathological correlations with treatment on follow-up liver biopsies. World J Gastroenterol 2010; 16(12): 1487-1494 [PMID: 20333789 DOI: 10.3748/wjg.v16.i12.1487] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
535 Duncan A, Gallacher G, Willox L. The role of the clinical biochemist in detection of zinc-induced copper deficiency. Ann Clin Biochem 2016;53:298-301. [DOI: 10.1177/0004563215595429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
536 Litwin T, Gromadzka G, Szpak GM, Jabłonka-Salach K, Bulska E, Członkowska A. Brain metal accumulation in Wilson's disease. J Neurol Sci 2013;329:55-8. [PMID: 23597670 DOI: 10.1016/j.jns.2013.03.021] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
537 Gromadzka G, Wierzbicka D, Litwin T, Przybyłkowski A. Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson's disease. Biometals 2021;34:407-14. [PMID: 33555495 DOI: 10.1007/s10534-021-00289-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
538 Yu XE, Gao S, Yang RM, Han YZ. MR Imaging of the Brain in Neurologic Wilson Disease. AJNR Am J Neuroradiol 2019;40:178-83. [PMID: 30635331 DOI: 10.3174/ajnr.A5936] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 11.5] [Reference Citation Analysis]
539 Pfeiffer RF. Wilson Disease. Continuum (Minneap Minn). 2016;22:1246-1261. [PMID: 27495207 DOI: 10.1212/con.0000000000000350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
540 Poujois A, Poupon J, Woimant F. Direct Determination of Non-Ceruloplasmin-Bound Copper in Plasma. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 249-55. [DOI: 10.1016/b978-0-12-810532-0.00022-7] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
541 Kim D, Kim SB, Ryu JL, Hong H, Chang JH, Yoo TJ, Jin X, Park HJ, Han C, Lee BH, Choi JH, Yoo HW, Kim JH, Woo DH. Human Embryonic Stem Cell-Derived Wilson's Disease Model for Screening Drug Efficacy. Cells 2020;9:E872. [PMID: 32252475 DOI: 10.3390/cells9040872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
542 Plitz T, Boyling L. Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease. Xenobiotica 2019;49:332-8. [DOI: 10.1080/00498254.2018.1443352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
543 Cerrada-Gimenez M, Weisell J, Hyvönen MT, Park MH, Alhonen L, Vepsäläinen J, Keinänen TA. Complex N-acetylation of triethylenetetramine. Drug Metab Dispos 2011;39:2242-9. [PMID: 21878558 DOI: 10.1124/dmd.111.041798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
544 Sturm E, Piersma FE, Tanner MS, Socha P, Roberts EA, Shneider BL. Controversies and Variation in Diagnosing and Treating Children With Wilson Disease: Results of an International Survey. Journal of Pediatric Gastroenterology & Nutrition 2016;63:82-7. [DOI: 10.1097/mpg.0000000000001102] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
545 Litwin T, Dzieżyc K, Karliński M, Chabik G, Czepiel W, Członkowska A. Early neurological worsening in patients with Wilson's disease. J Neurol Sci 2015;355:162-7. [PMID: 26071888 DOI: 10.1016/j.jns.2015.06.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 9.4] [Reference Citation Analysis]
546 Oe S, Honma Y, Yabuki K, Morino K, Kumamoto K, Hayashi T, Kusanaga M, Ogino N, Minami S, Shibata M, Abe S, Harada M. Importance of a Liver Biopsy in the Management of Wilson Disease. Intern Med 2020;59:77-81. [PMID: 31511488 DOI: 10.2169/internalmedicine.3440-19] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
547 Faulkes RE, Chauhan A, Knox E, Johnston T, Thompson F, Ferguson J. Review article: chronic liver disease and pregnancy. Aliment Pharmacol Ther 2020;52:420-9. [PMID: 32598048 DOI: 10.1111/apt.15908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
548 Roberts EA, Cox DW. Wilson Disease. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 1110-26. [DOI: 10.1016/b978-1-4377-0881-3.00063-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
549 Ganesh R, Suresh N, Vasanthi T, Sathiyasekaran M, Thulasiraman R. A 6-year-old boy with Wilson disease-A diagnostic dilemma.Indian J Gastroenterol. 2017;36:149-154. [PMID: 28435998 DOI: 10.1007/s12664-017-0746-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
550 Dong QY, Wu ZY. Advance in the pathogenesis and treatment of Wilson disease. Transl Neurodegener 2012;1:23. [PMID: 23210912 DOI: 10.1186/2047-9158-1-23] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
551 Rak K, Łoźna K, Styczyńska M, Bobak Ł, Bronkowska M. Oxidative Stress at Birth Is Associated with the Concentration of Iron and Copper in Maternal Serum. Nutrients 2021;13:1491. [PMID: 33924889 DOI: 10.3390/nu13051491] [Reference Citation Analysis]
552 Han Y, Cheng H, Toledo JB, Wang X, Li B, Han Y, Wang K, Fan Y. Impaired functional default mode network in patients with mild neurological Wilson's disease. Parkinsonism Relat Disord 2016;30:46-51. [PMID: 27372239 DOI: 10.1016/j.parkreldis.2016.06.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
553 Pandyan DA, Giri GVV, Shanthi K, Suthanraj AK, Kumar S. Copper extraction: Dental consideration for Wilson's disease - An uncommon case report. Natl J Maxillofac Surg 2019;10:235-7. [PMID: 31798263 DOI: 10.4103/njms.NJMS_60_18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
554 Li X, Lu Z, Lin Y, Lu X, Xu Y, Cheng J, Shao Y, Su X, Liu Z, Sheng H, Cai Y, Li T, Zhou Z, Tan J, Liu H, Huang Y, Liu L, Zeng C. Clinical features and mutational analysis in 114 young children with Wilson disease from South China. Am J Med Genet A 2019;179:1451-8. [PMID: 31172689 DOI: 10.1002/ajmg.a.61254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
555 Weiss KH, Schäfer M, Gotthardt DN, Angerer A, Mogler C, Schirmacher P, Schemmer P, Stremmel W, Sauer P. Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease. Clin Transplant. 2013;27:914-922. [PMID: 24118554 DOI: 10.1111/ctr.12259] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
556 Kodama H, Fujisawa C, Bhadhprasit W. Pathology, clinical features and treatments of congenital copper metabolic disorders--focus on neurologic aspects. Brain Dev 2011;33:243-51. [PMID: 21112168 DOI: 10.1016/j.braindev.2010.10.021] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
557 O'Brien A, Williams R. Rapid diagnosis of Wilson disease in acute liver failure: no more waiting for the ceruloplasmin level? Hepatology 2008;48:1030-2. [PMID: 18821595 DOI: 10.1002/hep.22587] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
558 Ranucci G, Di Dato F, Leone F, Vajro P, Spagnuolo MI, Iorio R. Penicillamine-induced Elastosis Perforans Serpiginosa in Wilson Disease: Is Useful Switching to Zinc? Journal of Pediatric Gastroenterology & Nutrition 2017;64:e72-3. [DOI: 10.1097/mpg.0000000000000613] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
559 Saporito-Magriñá CM, Musacco-Sebio RN, Andrieux G, Kook L, Orrego MT, Tuttolomondo MV, Desimone MF, Boerries M, Borner C, Repetto MG. Copper-induced cell death and the protective role of glutathione: the implication of impaired protein folding rather than oxidative stress. Metallomics 2018;10:1743-54. [PMID: 30311620 DOI: 10.1039/c8mt00182k] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 6.7] [Reference Citation Analysis]
560 Li H, Liu L, Li Y, He S, Liu Y, Li J, Tao R, Li W, Shang S. Familial screening of children with Wilson disease: Necessity of screening in previous generation and screening methods. Medicine (Baltimore) 2018;97:e11405. [PMID: 29979436 DOI: 10.1097/MD.0000000000011405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
561 Chen JC, Chuang CH, Wang JD, Wang CW. Combination Therapy Using Chelating Agent and Zinc for Wilson's Disease. J Med Biol Eng 2015;35:697-708. [PMID: 26692828 DOI: 10.1007/s40846-015-0087-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
562 Summer KH, Lichtmannegger J, Bandow N, Choi DW, DiSpirito AA, Michalke B. The biogenic methanobactin is an effective chelator for copper in a rat model for Wilson disease. J Trace Elem Med Biol. 2011;25:36-41. [PMID: 21242075 DOI: 10.1016/j.jtemb.2010.12.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
563 Braiterman LT, Murthy A, Jayakanthan S, Nyasae L, Tzeng E, Gromadzka G, Woolf TB, Lutsenko S, Hubbard AL. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B. Proc Natl Acad Sci USA. 2014;111:E1364-E1373. [PMID: 24706876 DOI: 10.1073/pnas.1314161111] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
564 Tang S, Bai L, Hou W, Hu Z, Chen X, Zhao J, Liang C, Zhang W, Duan Z, Zheng S. Comparison of the Effectiveness and Safety of d-Penicillamine and Zinc Salt Treatment for Symptomatic Wilson Disease: A Systematic Review and Meta‐Analysis. Front Pharmacol 2022;13:847436. [DOI: 10.3389/fphar.2022.847436] [Reference Citation Analysis]
565 Hou H, Chen D, Liu J, Feng L, Zhang J, Liang X, Xu Y, Li X. Clinical and Genetic Analysis in Neurological Wilson’s Disease Patients With Neurological Worsening Following Chelator Therapy. Front Genet 2022;13:875694. [DOI: 10.3389/fgene.2022.875694] [Reference Citation Analysis]
566 Mohr I, Weiss KH. Current anti-copper therapies in management of Wilson disease. Ann Transl Med 2019;7:S69. [PMID: 31179306 DOI: 10.21037/atm.2019.02.48] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
567 Schilsky ML. Liver transplantation for Wilson's disease. Ann N Y Acad Sci. 2014;1315:45-49. [PMID: 24820352 DOI: 10.1111/nyas.12454] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
568 Gaun S, Ali SA, Singh P, Patwa J, Flora SJS, Datusalia AK. Melatonin ameliorates chronic copper-induced lung injury. Environ Sci Pollut Res Int 2022. [PMID: 35359208 DOI: 10.1007/s11356-022-19930-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
569 Sarkar M, Brady CW, Fleckenstein J, Forde KA, Khungar V, Molleston JP, Afshar Y, Terrault NA. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:318-65. [PMID: 32946672 DOI: 10.1002/hep.31559] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 16.0] [Reference Citation Analysis]
570 Fang WY, Abuduxikuer K, Shi P, Qiu YL, Zhao J, Li YC, Zhang XY, Wang NL, Xie XB, Lu Y, Knisely AS, Wang JS. Pediatric Wilson disease presenting as acute liver failure: Prognostic indices. World J Clin Cases 2021; 9(14): 3273-3286 [PMID: 34002136 DOI: 10.12998/wjcc.v9.i14.3273] [Reference Citation Analysis]
571 Yousefi M, Yousefi M, Gharravi AM. Late-onset Wilson disease in older patient without ophthalmological findings, a case report. Clin Case Rep 2019;7:1253-8. [PMID: 31183105 DOI: 10.1002/ccr3.2203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
572 Kasztelan-Szczerbinska B, Cichoz-Lach H. Wilson's Disease: An Update on the Diagnostic Workup and Management. J Clin Med 2021;10:5097. [PMID: 34768617 DOI: 10.3390/jcm10215097] [Reference Citation Analysis]
573 Yu Y, Cui Y, Niedernhofer LJ, Wang Y. Occurrence, Biological Consequences, and Human Health Relevance of Oxidative Stress-Induced DNA Damage. Chem Res Toxicol 2016;29:2008-39. [PMID: 27989142 DOI: 10.1021/acs.chemrestox.6b00265] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 11.8] [Reference Citation Analysis]
574 Litwin T, Bembenek J, Antos A, Przybyłkowski A, Skowrońska M, Kurkowska-Jastrzębska I, Członkowska A. Liver transplantation as a treatment for Wilson's disease with neurological presentation: a systematic literature review. Acta Neurol Belg 2022;122:505-18. [PMID: 35080708 DOI: 10.1007/s13760-022-01872-w] [Reference Citation Analysis]
575 Kanwar P, Kowdley KV. Metal Storage Disorders. Medical Clinics of North America 2014;98:87-102. [DOI: 10.1016/j.mcna.2013.09.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
576 Mainardi V, Rando K, Valverde M, Olivari D, Castelli J, Rey G, Gerona S. Acute Liver Failure due to Wilson Disease: Eight Years of the National Liver Transplant Program in Uruguay. Ann Hepatol. 2019;18:187-192. [PMID: 31113589 DOI: 10.5604/01.3001.0012.7911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
577 Trocello J, Broussolle E, Girardot-tinant N, Pelosse M, Lachaux A, Lloyd C, Woimant F. Wilson's disease, 100 years later…. Revue Neurologique 2013;169:936-43. [DOI: 10.1016/j.neurol.2013.05.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
578 Kerkar N, Roberts EA. Wilson Disease in Infancy through Adolescence. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 179-93. [DOI: 10.1016/b978-0-12-810532-0.00017-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
579 Aggarwal A, Bhatt M. Advances in Treatment of Wilson Disease. Tremor Other Hyperkinet Mov (N Y) 2018;8:525. [PMID: 29520330 DOI: 10.7916/D841881D] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
580 Weiss KH, Stremmel W. Clinical considerations for an effective medical therapy in Wilson's disease: Treatment efficacy in Wilson disease. Ann N Y Acad Sci 2014;1315:81-5. [DOI: 10.1111/nyas.12437] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
581 Bennett JT, Schwarz KB, Swanson PD, Hahn SH. An exceptional family with three consecutive generations affected by Wilson disease. JIMD Rep 2013;10:1-4. [PMID: 23430806 DOI: 10.1007/8904_2012_206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
582 Kucinskas L, Jeroch J, Vitkauskiene A, Sakalauskas R, Petrenkiene V, Kucinskas V, Naginiene R, Schmidt H, Kupcinskas L. High frequency of the c.3207C>A (p.H1069Q) mutation in ATP7B gene of Lithuanian patients with hepatic presentation of Wilson's disease. World J Gastroenterol 2008;14:5876-9. [PMID: 18855987 DOI: 10.3748/wjg.14.5876] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
583 Ferrara J, Jankovic J. Epidemiology and Management of Essential Tremor in Children: . Pediatric Drugs 2009;11:293-307. [DOI: 10.2165/11316050-000000000-00000] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
584 Linn FH, Houwen RH, van Hattum J, van der Kleij S, van Erpecum KJ. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Hepatology 2009;50:1442-52. [PMID: 19731238 DOI: 10.1002/hep.23182] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
585 Socha P, Janczyk W, Dhawan A, Baumann U, D'Antiga L, Tanner S, Iorio R, Vajro P, Houwen R, Fischler B, Dezsofi A, Hadzic N, Hierro L, Jahnel J, McLin V, Nobili V, Smets F, Verkade HJ, Debray D. Wilson's Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66:334-344. [PMID: 29341979 DOI: 10.1097/mpg.0000000000001787] [Cited by in Crossref: 59] [Cited by in F6Publishing: 13] [Article Influence: 19.7] [Reference Citation Analysis]
586 van den Berghe PV, Stapelbroek JM, Krieger E, de Bie P, van de Graaf SF, de Groot RE, van Beurden E, Spijker E, Houwen RH, Berger R, Klomp LW. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin. Hepatology 2009;50:1783-95. [PMID: 19937698 DOI: 10.1002/hep.23209] [Cited by in Crossref: 98] [Cited by in F6Publishing: 85] [Article Influence: 7.5] [Reference Citation Analysis]
587 Abuduxikuer K, Wang JS. Zinc mono-therapy in pre-symptomatic Chinese children with Wilson disease: a single center, retrospective study. PLoS One. 2014;9:e86168. [PMID: 24475083 DOI: 10.1371/journal.pone.0086168] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
588 Nunes VS, Andrade AR, Guedes ALV, Diniz MA, Oliveira CP, CanÇado ELR. DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH LOW LEVELS OF FREE COPPER AND OF CERULOPLASMIN. Arq Gastroenterol 2020;57:249-53. [PMID: 32935743 DOI: 10.1590/S0004-2803.202000000-47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
589 Lee TH, Kim WR, Poterucha JJ. Evaluation of elevated liver enzymes. Clin Liver Dis 2012;16:183-98. [PMID: 22541694 DOI: 10.1016/j.cld.2012.03.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
590 O'Leary JG, Yachimski PS, Friedman LS. Surgery in the patient with liver disease. Clin Liver Dis. 2009;13:211-231. [PMID: 19442915 DOI: 10.1016/j.cld.2009.02.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
591 Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA. AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology 2013;58:2142-52. [PMID: 23775835 DOI: 10.1002/hep.26578] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
592 Mura G, Zimbrean PC, Demelia L, Carta MG. Psychiatric comorbidity in Wilson's disease. Int Rev Psychiatry 2017;29:445-62. [PMID: 28681670 DOI: 10.1080/09540261.2017.1311845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
593 Fenu M, Liggi M, Demelia E, Sorbello O, Civolani A, Demelia L. Kayser-Fleischer ring in Wilson's disease: a cohort study. Eur J Intern Med 2012;23:e150-6. [PMID: 22863441 DOI: 10.1016/j.ejim.2012.04.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
594 Greig JA, Nordin JML, Smith MK, Ashley SN, Draper C, Zhu Y, Bell P, Buza EL, Wilson JM. A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease. Human Gene Therapy Clinical Development 2019;30:29-39. [DOI: 10.1089/humc.2018.219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
595 Koboldt DC, Hickey SE, Chaudhari BP, Mihalic Mosher T, Bedrosian T, Crist E, Kaler SG, McBride K, White P, Wilson RK. Early-onset Wilson disease caused by ATP7B exon skipping associated with intronic variant. Cold Spring Harb Mol Case Stud 2020;6:a005306. [PMID: 32532881 DOI: 10.1101/mcs.a005306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
596 Hsiao H, Lin J, Wu C, Lin J, Hsia S. An unusual cause of headache and hypertension. The American Journal of Emergency Medicine 2013;31:272.e5-6. [DOI: 10.1016/j.ajem.2012.05.010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
597 El Balkhi S, Poupon J, Trocello J, Leyendecker A, Massicot F, Galliot-guilley M, Woimant F. Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects. Anal Bioanal Chem 2009;394:1477-84. [DOI: 10.1007/s00216-009-2809-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
598 Baldari S, Di Rocco G, Toietta G. Current Biomedical Use of Copper Chelation Therapy. Int J Mol Sci 2020;21:E1069. [PMID: 32041110 DOI: 10.3390/ijms21031069] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 16.5] [Reference Citation Analysis]
599 Lin LJ, Wang DX, Zheng CQ, Cao N, Ding NN. Wilson's disease with hepatic manifestations as the first presentation: An analysis of 93 cases. Shijie Huaren Xiaohua Zazhi 2013; 21(9): 820-823 [DOI: 10.11569/wcjd.v21.i9.820] [Reference Citation Analysis]
600 Muratori P, Lenzi M, Cassani F, Lalanne C, Muratori L. Diagnostic approach to autoimmune hepatitis. Expert Rev Clin Immunol 2017;13:769-79. [PMID: 28480763 DOI: 10.1080/1744666X.2017.1327355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
601 Jernajczyk W, Litwin T, Członkowska A, Bembenek JP. Sleep disturbances in newly diagnosed treatment-naïve patients with Wilson's disease. Acta Neurol Belg 2022;122:745-51. [PMID: 35322347 DOI: 10.1007/s13760-022-01915-2] [Reference Citation Analysis]
602 Parisi S, Polishchuk EV, Allocca S, Ciano M, Musto A, Gallo M, Perone L, Ranucci G, Iorio R, Polishchuk RS, Bonatti S. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells. Sci Rep 2018;8:6247. [PMID: 29674751 DOI: 10.1038/s41598-018-24717-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
603 Katayama K, Hosui A, Sakai Y, Itou M, Matsuzaki Y, Takamori Y, Hosho K, Tsuru T, Takikawa Y, Michitaka K, Ogawa E, Miyoshi Y, Ito T, Ida S, Hamada I, Miyoshi K, Kodama H, Takehara T. Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic Liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment Trial. Biol Trace Elem Res 2020;195:71-81. [PMID: 31392541 DOI: 10.1007/s12011-019-01851-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
604 Eller AW, Gorovoy IR, Mayercik VA. Yellow corneal ring associated with vitamin supplementation for age-related macular degeneration. Ophthalmology 2012;119:1011-6. [PMID: 22330962 DOI: 10.1016/j.ophtha.2011.10.032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
605 Zhao T, Fang Z, Tian J, Liu J, Xiao Y, Li H, Chen B. Imaging Kayser-Fleischer Ring in Wilson Disease Using In Vivo Confocal Microscopy. Cornea 2019;38:332-7. [PMID: 30601285 DOI: 10.1097/ICO.0000000000001844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
606 Karpen HE, Karpen SJ. Bile Acid Metabolism During Development. Fetal and Neonatal Physiology. Elsevier; 2017. pp. 913-929.e4. [DOI: 10.1016/b978-0-323-35214-7.00095-0] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
607 Rosencrantz RA, Schilsky ML. Mining for a diagnosis of Wilson's disease in children: genetics, score, and ore. Hepatology 2010;52:1872-4. [PMID: 21105104 DOI: 10.1002/hep.24054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
608 Falcone E, Okafor M, Vitale N, Raibaut L, Sour A, Faller P. Extracellular Cu2+ pools and their detection: From current knowledge to next-generation probes. Coordination Chemistry Reviews 2021;433:213727. [DOI: 10.1016/j.ccr.2020.213727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
609 Culpepper T, Kelkar AH. Undiagnosed Wilson's Disease and Fibromyalgia Masking Bowel Perforation. Cureus 2021;13:e13504. [PMID: 33786213 DOI: 10.7759/cureus.13504] [Reference Citation Analysis]
610 Christensen CK, Walsh L. Movement Disorders and Neurometabolic Diseases. Semin Pediatr Neurol 2018;25:82-91. [PMID: 29735120 DOI: 10.1016/j.spen.2018.02.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
611 Janka SS, Bätzing J, Laux G, Holstiege J, Wahler S, Merle U, Mehrabi A, Mohr I, Weiss KH, Mieth M. [Retrospective cross-sectional study based on nationwide data of drug prescriptions and contractional data of outpatient offices regarding Morbus Wilson's disease]. Z Gastroenterol 2020;58:1054-64. [PMID: 33197948 DOI: 10.1055/a-1246-3190] [Reference Citation Analysis]
612 Gupta P, Choksi M, Goel A, Zachariah U, Sajith KG, Ramachandran J, Chandy G, Kurian G, Rebekah G, Eapen CE. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting. Indian J Gastroenterol 2018;37:31-8. [PMID: 29457214 DOI: 10.1007/s12664-018-0829-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
613 Litwin T, Dušek P, Członkowska A. Symptomatic treatment of neurologic symptoms in Wilson disease. Handb Clin Neurol 2017;142:211-23. [PMID: 28433105 DOI: 10.1016/B978-0-444-63625-6.00018-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
614 Baykal M, Karapolat S. Anesthetic management of a pediatric patient with wilsons disease. J Clin Med Res 2010;2:99-101. [PMID: 21811529 DOI: 10.4021/jocmr2010.04.292w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
615 Jing Z, Daojun X, Yanbing G, Yajun L, Liangyong L, Hui H, Juan Z, Huaizhen C, Meixia W. Evaluation of efficacy and safety of gandouling plus sodium dimercaptosulphonate in treatment of patients with neurological Wilson's disease from China. Journal of Traditional Chinese Medicine 2018;38:781-6. [DOI: 10.1016/s0254-6272(18)30919-1] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
616 Liu J, Luan J, Zhou X, Cui Y, Han J. Epidemiology, diagnosis, and treatment of Wilson's disease. Intractable Rare Dis Res. 2017;6:249-255. [PMID: 29259852 DOI: 10.5582/irdr.2017.01057] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
617 Kenney GE, Rosenzweig AC. Chemistry and biology of the copper chelator methanobactin. ACS Chem Biol 2012;7:260-8. [PMID: 22126187 DOI: 10.1021/cb2003913] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
618 Erlinger S. A microbial peptide to rescue severe and fulminant Wilson disease? Clinics and Research in Hepatology and Gastroenterology 2016;40:647-9. [DOI: 10.1016/j.clinre.2016.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
619 Appenzeller-Herzog C, Mathes T, Heeres MLS, Weiss KH, Houwen RHJ, Ewald H. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies. Liver Int. 2019;39:2136-2152. [PMID: 31206982 DOI: 10.1111/liv.14179] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
620 Sandahl TD, Gormsen LC, Kjaergaard K, Vendelbo MH, Munk DE, Munk OL, Bender D, Keiding S, Vase KH, Frisch K, Vilstrup H, Ott P. The pathophysiology of Wilson's disease visualized: A human 64 Cu PET study. Hepatology 2022;75:1461-70. [PMID: 34773664 DOI: 10.1002/hep.32238] [Reference Citation Analysis]
621 Li H, Tao R, Liu L, Shang S. Population screening and diagnostic strategies in screening family members of Wilson's disease patients. Ann Transl Med. 2019;7:S59. [PMID: 31179296 DOI: 10.21037/atm.2019.03.54] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
622 Kodama H, Fujisawa C. Copper metabolism and inherited copper transport disorders: molecular mechanisms, screening, and treatment. Metallomics 2009;1:42-52. [DOI: 10.1039/b816011m] [Cited by in Crossref: 49] [Cited by in F6Publishing: 2] [Article Influence: 3.8] [Reference Citation Analysis]
623 Tatsumi Y, Kato A, Kato K, Hayashi H. The interactions between iron and copper in genetic iron overload syndromes and primary copper toxicoses in Japan: Iron copper interaction in hemochromatosis and Wilson disease. Hepatol Res 2018;48:679-91. [DOI: 10.1111/hepr.13200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
624 Seidi S, Alavi L. Novel and Rapid Deep Eutectic Solvent (DES) Homogeneous Liquid–Liquid Microextraction (HLLME) with Flame Atomic Absorption Spectrometry (FAAS) Detection for the Determination of Copper in Vegetables. Analytical Letters 2019;52:2092-106. [DOI: 10.1080/00032719.2019.1598425] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
625 Peedikayil MC, Al Ashgar HI, Al Mousa A, Al Sebayel M, Al Kahtani K, Alkhail FA. Liver transplantation in Wilson’s disease: Single center experience from Saudi Arabia. World J Hepatol 2013; 5(3): 127-132 [PMID: 23556045 DOI: 10.4254/wjh.v5.i3.127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
626 Li X, Zhang W, Zhou D, Lv T, Xu A, Wang H, Zhao X, Zhang B, Li Y, Jia S, Wang Y, Wang X, Wu Z, Duan W, Wang Q, Nan Y, Shang J, Jiang W, Chen Y, Zheng S, Liu M, Sun L, You H, Jia J, Ou X, Huang J. Complex ATP7B mutation patterns in Wilson disease and evaluation of a yeast model for functional analysis of variants. Hum Mutat 2019;40:552-65. [PMID: 30702195 DOI: 10.1002/humu.23714] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
627 Zeng DW, Liu YR, Zhang JM, Zhu YY, Lin S, You J, Li YB, Chen J, Zheng Q, Jiang JJ, Dong J. Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease. PLoS One. 2013;8:e77942. [PMID: 24282481 DOI: 10.1371/journal.pone.0077942] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]